Search Within

LYMPHOMA
Results 1 - 406 of 406
Anaplastic Lymphoma Kinase as a Therapeutic Target in Anaplastic Large Cell Lymphoma, Non-Small Cell Lung Cancer and Neuroblastoma

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 10,Issue: 3
Page: 236-249
Authors: Mangeng Cheng and Gregory R. Ott

Hepatitis C Virus Infection and Antiviral Treatment in Marginal Zone Lymphomas

Journal: Current Clinical Pharmacology
Volume: 5,Issue: 2
Page: 74-81
Authors: Luca Arcaini and Raffaele Bruno

Diffuse Large B-Cell Lymphoma with Involvement of the Chest Wall

Journal: Current Respiratory Medicine Reviews
Volume: 9,Issue: 2
Page: 75-78
Authors: William H. Porr, Jonathan L. Henderson and Michael J. Morris

Composite Lymphomas: A Challenging Entity

Journal: Current Cancer Therapy Reviews
Volume: 10,Issue: 2
Page: 80-89
Authors: Sotirios Sachanas, Gerassimos A. Pangalis, Christina Kalpadakis, Xanthi Yiakoumis, Maria Moschogiannis, Marie-Christine Kyrtsonis, Theodoros P. Vassilakopoulos, Pantelis Tsirkinidis, Flora Kontopidou, Styliani Kokoris, Marina Siakantaris, Nora-Athina Viniou, Pinelopi Korkolopoulou, Helen Papadaki, Panayiotis Panayiotidis and Maria Angelopoulou

Diffuse Large B-Cell Lymphoma Presenting as an Anterior Chest Wall Mass: A Case Report and Literature Review

Journal: Current Respiratory Medicine Reviews
Volume: 5,Issue: 4
Page: 239-241
Authors: Chrissy A. Navejar and Michael J. Morris

Clinical Use of Rituximab in Patients with HIV Related Lymphoma and Multicentric Castlemans Disease

Journal: Current Drug Delivery
Volume: 9,Issue: 1
Page: 41-51
Authors: Erin Reid, Ajay Nooka, Jawaunna Blackmon and Mary Jo Lechowicz

Extranodal Marginal Zone B-Cell Lymphoma of Mucosa Associated Lymphoid Tissue Presenting as Multiple Pulmonary Lesions: Case Report and Review of the Literature

Journal: Current Respiratory Medicine Reviews
Volume: 3,Issue: 1
Page: 53-56
Authors: Bobbak Vahid, Bernadette Wildmore and Paul Marik

Sjogrens Syndrome and Lymphoma Development

Journal: Current Immunology Reviews
Volume: 3,Issue: 4
Page: 289-296
Authors: Hisanori Umehara, Lingli Dong, Yasufumi Masaki, Masao Tanaka, Toshihiro Fukushima and Toshiro Okazaki

Antiangiogenic Therapies in Non-Hodgkin's Lymphoma

Journal: Current Cancer Drug Targets
Volume: 11,Issue: 9
Page: 1030-1043
Authors: J. Ruan

Possible Mechanisms of Lymphoma Development in Sjogren’s Syndrome

Journal: Current Immunology Reviews
Volume: 9,Issue: 1
Page: 13-22
Authors: Lingli Dong, Yu Chen, Yasufumi Masaki, Toshiro Okazaki and Hisanori Umehara

Clinical Development of mTOR Inhibitors: A Focus on Lymphoma

Journal: Reviews on Recent Clinical Trials
Volume: 2,Issue: 2
Page: 103-110
Authors: Sonali M. Smith

Is There an Increased Risk of Lymphoma and Malignancies Under Anti- TNF Therapy in IBD?

Journal: Current Drug Targets
Volume: 11,Issue: 2
Page: 179-186
Authors: P. L. Lakatos and P. Miheller

mTOR Inhibition in Lymphoma: A Rational and Promising Strategy

Journal: Letters in Drug Design & Discovery
Volume: 4,Issue: 3
Page: 224-231
Authors: Sonali M. Smith and Koen van Besien

Decision Support System for Lymphoma Classification

Journal: Current Medical Imaging Reviews
Volume: 13,Issue: 1
Page: 89-98
Authors: Ahmed E-S. Negm, Ahmed H. Kandil and Osama A. E-F. Hassan

The Bcl10 / Malt1 Signaling Pathway as a Drug Target in Lymphoma

Journal: Current Drug Targets
Volume: 7,Issue: 10
Page: 1335-1340
Authors: P. Jost, C. Peschel and J. Ruland

Aberrant Expression of MicroRNAs in B-cell Lymphomas

Journal: MicroRNA
Volume: 5,Issue: 2
Page: 87-105
Authors: Carla Sole, Erika Larrea, Lorea Manterola, Ibai Goicoechea, María Armesto, María Arestin, María M. Caffarel, Angela M. Araujo, Marta Fernandez-Mercado, María Araiz and Charles H. Lawrie

New Pharmaceutical Treatment of Gastric MALT Lymphoma: Anti-angiogenesis Treatment using VEGF Receptor Antibodies and Celecoxib

Journal: Current Pharmaceutical Design
Volume: 20,Issue: 7
Page: 1097-1103
Authors: Masahiko Nakamura, Tetsufumi Takahashi, Hidenori Matsui, Shinichi Takahashi, Somay Y. Murayama, Hidekazu Suzuki and Kanji Tsuchimoto

Oncogenic MicroRNAs in the Genesis of Leukemia and Lymphoma

Journal: Current Pharmaceutical Design
Volume: 20,Issue: 33
Page: 5260-5267
Authors: Yanyan Pan, Mei Meng, Gaochuan Zhang, Hongyan Han and Quansheng Zhou

Differentiation of Glioblastoma and Lymphoma Using Feature Extraction and Support Vector Machine

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 16,Issue: 2
Page: 160-168
Authors: Zhangjing Yang, Piaopiao Feng, Tian Wen, Minghua Wan and Xunning Hong

Molecular Analysis of Primary Central Nervous System and Primary Intraocular Lymphomas.

Journal: Current Molecular Medicine
Volume: 1,Issue: 2
Page: 259-272
Authors: N. Tuaillon and C. C. Chan

Targeted Strategies in the Treatment of Primary Gastric Lymphomas: From Rituximab to Recent Insights into Potential New Drugs

Journal: Current Medicinal Chemistry
Volume: 21,Issue: 8
Page: 1005-1016
Authors: Francesca Merchionne, Pasquale Iacopino, Carla Minoia, Angela Iacobazzi, Antonio Rana, Simona Serrati, Giacoma De Tullio, Giacomo Loseto, Angela Lapietra, Annunziata Lucarelli and Attilio Guarini

Rituxan® Immunotherapy and Zevalin® Radioimmunotherapy in the Treatment of Non-Hodgkins Lymphoma

Journal: Current Pharmaceutical Biotechnology
Volume: 4,Issue: 4
Page: 221-238
Authors: Christine A. White

Design and Pre-Clinical Development of Epitope-based DNA Vaccines Against B-Cell Lymphoma

Journal: Current Gene Therapy
Volume: 11,Issue: 5
Page: 414-422
Authors: Sandra Iurescia, Daniela Fioretti, Vito Michele Fazio and Monica Rinaldi

The Role of Major Histocompatibility Complex Polymorphisms in the Incidence and Outcome of Non-Hodgkin Lymphoma

Journal: Current Immunology Reviews
Volume: 5,Issue: 4
Page: 300-310
Authors: Jacek Nowak, Przemyslaw Juszczynski and Krzysztof Warzocha

Impact of PET on the Radiation Treatment of Hodgkins Lymphoma

Journal: Current Radiopharmaceuticals
Volume: 2,Issue: 3
Page: 169-174
Authors: Annibale Versari, Cinzia Iotti and Francesco Merli

Molecular Cloning of a Novel PPEF-1 Gene Variant from a T-Cell Lymphoblastic Lymphoma Cell Line

Journal: Recent Patents on DNA & Gene Sequences (DIscontinued)
Volume: 6,Issue: 1
Page: 72-77
Authors: Ping Ho, Ken-Shwo Dai and Hui-Ling Chen

Novel Pharmacodynamic Approach to Assess Obatoclax (GX15-070) and Bortezomib (BTZ) Synergism in Non-Hodgkin’s Lymphoma

Journal: Clinical Cancer Drugs
Volume: 2,Issue: 1
Page: 44-53
Authors: Karen E. Thudium, Lance Wollenberg, Cory Mavis, Jenny Gu, Gerald J. Fetterly, Myron S. Czuczman and Francisco J. Hernandez-Ilizaliturri

Classical and Non-Classical Thyroid Hormone Intracellular Pathways Involved in T Lymphoma Growth

Journal: Immunology‚ Endocrine & Metabolic Agents in Medicinal Chemistry
Volume: 15,Issue: 1
Page: 37-42
Authors: Maria L.B. Arcos, Helena Sterle, Florencia Cayrol, Maria C.D. Flaque, Eduardo Valli, Maria A. Paulazo, Alicia J. Klecha and Graciela A. Cremaschi

Cell Cycle Inhibition in Malignant Lymphoma: Disease Control by Attacking the Cellular Proliferation Machinery

Journal: Current Drug Targets
Volume: 7,Issue: 10
Page: 1349-1359
Authors: Ingo Ringshausen, Christian Peschel and Thomas Decker

Notch Signaling in Leukemias and Lymphomas

Journal: Current Molecular Medicine
Volume: 8,Issue: 1
Page: 51-59
Authors: Franziska Jundt, Rolf Schwarzer and Bernd Dorken

Exploratory Study on the Effects of Biodegradable Nanoparticles with Drugs on Malignant B Cells and on a Human/Mouse Model of Burkitt Lymphoma

Journal: Current Clinical Pharmacology
Volume: 5,Issue: 4
Page: 246-250
Authors: Gustavo H. Marin, Eduardo Mansilla, Nelly Mezzaroba, Sonia Zorzet, Luis Nunez, Gustavo Larsen, Jose M. Tau, Alberto Maceira, Ruben Spretz, Carol Mertz, Sabrina Ingrao, Claudio Tripodo, Francesco Tedesco and Paolo Macor

New Drugs for Follicular Lymphoma in Older Adults

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 14,Issue: 5
Page: 657-664
Authors: Anna Schmitt and Pierre Soubeyran

Lymphoma and the Control of B Cell Growth and Differentiation

Journal: Current Molecular Medicine
Volume: 6,Issue: 3
Page: 291-308
Authors: Lixin Rui and Christopher C. Goodnow

Angiogenesis in Lymphoma: A Short Review

Journal: Current Molecular Medicine
Volume: 5,Issue: 7
Page: 609-613
Authors: Anas Younes

A Storage Protein-Like Trypsin Inhibitor from the Moth Bean (Phaseolus acutifolius) with Antiproliferative Activity Toward Lymphoma Cells

Journal: Protein & Peptide Letters
Volume: 17,Issue: 6
Page: 782-788
Authors: D.Z. Ma, J. Sun, G.Q. Zhang, H.X. Wang and T.B. Ng

Novel Systemic Drugs for Cutaneous T-Cell Lymphoma

Journal: Recent Patents on Anti-Cancer Drug Discovery
Volume: 6,Issue: 1
Page: 70-93
Authors: Ewa Lech-Maranda, Ewa Robak and Tadeusz Robak

Primary Lung Lymphoma

Journal: Current Drug Target -Inflammation & Allergy
Volume: 3,Issue: 4
Page: 469-471
Authors: Daniele Vallisa, Elena Trabacchi and Luigi Cavanna

Current Perspectives on Cytokines for Anti-retroviral Therapy in AIDS Related B-cell Lymphomas

Journal: Current Drug Target -Infectious Disorders
Volume: 3,Issue: 2
Page: 137-149
Authors: V. Sharma

Identification of Novel Structurally Diverse Anaplastic Lymphoma Kinase Inhibitors Based on Pharmacophore Modeling, Virtual Screening and Molecular Docking

Journal: Combinatorial Chemistry & High Throughput Screening
Volume: 19,Issue: 9
Page: 691-704
Authors: Rong You, Lu Zhou, Liangliang Zhong, Xiaoli Li, Suwen Zhou and Yahui Tian

Highly Active Antiretroviral Therapy is Associated with Improved Survival among Patients with AIDS-Related Primary Central Nervous System Non-Hodgkins Lymphoma

Journal: Current HIV Research
Volume: 4,Issue: 3
Page: 375-378
Authors: Catherine Diamond, Thomas H. Taylor, Theresa Im, Mohammed Miradi, Mark Wallace and Hoda Anton-Culver

Parallel Gene Expression Profiling of Mantle Cell Lymphoma – How Do We Transform ´Omics Data into Clinical Practice

Journal: Current Genomics
Volume: 8,Issue: 3
Page: 171-179
Authors: Sara Ek and Carl A. K. Borrebaeck

Antibody-Targeted Immunotherapy for Treatment of Non-Hodgkins Lymphoma

Journal: Current Pharmaceutical Biotechnology
Volume: 1,Issue: 4
Page: 303-312
Authors: Christine A. White, Judy R. Berlfein and Antonio J. Grillo-Lopez

Potential of Plant-Derived Natural Products in the Treatment of Leukemia and Lymphoma

Journal: Current Drug Targets
Volume: 11,Issue: 7
Page: 812-822
Authors: David M. Lucas, Patrick C. Still, Lynette Bueno Perez, Michael R. Grever and A. Douglas Kinghorn

Notch and NF-κB Signaling Pathways in the Biology of Classical Hodgkin Lymphoma

Journal: Current Molecular Medicine
Volume: 11,Issue: 3
Page: 236-245
Authors: R. Schwarzer and F. Jundt

Immunological Aspects of Adult T-Cell Leukemia/Lymphoma (ATLL), a Possible Neoplasm of Regulatory T-Cells

Journal: Current Immunology Reviews
Volume: 4,Issue: 4
Page: 242-250
Authors: Yasuaki Yamada and Shimeru Kamihira

Pathogenesis of HIV-Associated Non-Hodgkin Lymphoma

Journal: Current HIV Research
Volume: 2,Issue: 3
Page: 215-221
Authors: Deirdre Killebrew and Bruce Shiramizu

Concurrent Administration of Rituximab and CHOP Chemotherapeutic Agents for Outpatients with CD20-positive Lymphoma

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 12,Issue: 7
Page: 829-834
Authors: Yoshihiro Yakushijin, Tomiko Tatsukawa, Takumi Yamaguchi, Takashi Egawa, Noriaki Hidaka, Keiko Ido, Katsuya Suemaru, Masaki Yasukawa and Hiroak Araki

Management Of Elderly Patients With Diffuse Large B-Cell Lymphomas

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 13,Issue: 9
Page: 1412-1418
Authors: Rosanna Ciancia, Umberto Tirelli, Josep-Maria Ribera and Michele Spina

MicroRNAs in Lymphoma: Regulatory Role and Biomarker Potential

Journal: Current Genomics
Volume: 16,Issue: 5
Page: 349-358
Authors: Marta Fernandez-Mercado, Lorea Manterola and Charles H. Lawrie

Targeting the Oncogenic Tyrosine Kinase NPM-ALK in Lymphoma: The Role of Murine Models in Defining Pathogenesis and Treatment Options

Journal: Current Drug Targets
Volume: 7,Issue: 10
Page: 1329-1334
Authors: Cornelius Miething, Christian Peschel and Justus Duyster

Rituximab The First Monoclonal Antibody Approved for the Treatment of Lymphoma

Journal: Current Pharmaceutical Biotechnology
Volume: 1,Issue: 1
Page: 1-9
Authors: A. J. Grillo-Lopez, C. A. White, B. K. Dallaire, C. L. Varns, C. D. Shen, A. Wei, J. E. Leonard, A. McClure, R. Weaver, S. Cairelli and J. Rosenberg

γ-Tocotrienol Induces Apoptosis in Human T Cell Lymphoma through Activation of Both Intrinsic and Extrinsic Pathways

Journal: Current Pharmaceutical Design
Volume: 17,Issue: 21
Page: 2176-2189
Authors: Chandan Wilankar, Nazir M. Khan, Rahul Checker, Deepak Sharma, Raghavendra Patwardhan, Vikram Gota, Santosh Kumar Sandur and T. P. A. Devasagayam

Signaling in Human B-Lymphoma Rafts

Journal: Immunology‚ Endocrine & Metabolic Agents in Medicinal Chemistry
Volume: 8,Issue: 4
Page: 366-374
Authors: S. Tauzin, H. Ding, B. Borisch and D. C. Hoessli

Incidence of Profound Hypogammaglobulinemia and Infection Rate in Lymphoma Patients Following the Combination of Chemotherapy and Rituximab

Journal: Recent Patents on Anti-Cancer Drug Discovery
Volume: 11,Issue: 2
Page: 228-235
Authors: Kalman Filanovsky, Edward B. Miller, Erica Sigler, Alain Berrebi and Lev Shvidel

Nano Conjugated PLGA-Chlorambucil: Synthesis In Vitro Anti Non- Hodgkin's Lymphoma Cellular Assay

Journal: Letters in Drug Design & Discovery
Volume: 14,Issue: 7
Page: 827-836
Authors: Saeed Akbarian, Jafar Sojoodi, Fatemeh Monnavari, Hossein Heidari, Pegah Khosravian, Hamid A. Javar, Artin Assadi, Rahimeh Rasouli, Mostafa Saffari, Seyed A.S. Shandiz, Hadi Hejazinia, Farnoor D. Omoomi, Mohammad Saffari and Mehdi S. Ardestani

Anti-CD3 Recombinant Diphtheria Immunotoxin Therapy of Cutaneous T Cell Lymphoma

Journal: Current Drug Targets
Volume: 10,Issue: 2
Page: 104-109
Authors: A. E. Frankel, S. L. Zuckero, A. A. Mankin, M. Grable, K. Mitchell, Y. J. Lee, D. M. Neville and J. H. Woo

Hodgkin Lymphoma in HIV Positive Patients

Journal: Current HIV Research
Volume: 8,Issue: 2
Page: 141-146
Authors: Nicolas Mounier, Michele Spina and Jean P. Spano

HIV-1 Nef Protein Visits B-Cells via Macrophage Nanotubes: A Mechanism for AIDS-Related Lymphoma Pathogenesis?

Journal: Current HIV Research
Volume: 8,Issue: 8
Page: 638-640
Authors: Susanna L. Lamers, Gary B. Fogel, Leanne C. Huysentruyt and Michael S. McGrath

Angiogenesis and AngiomiRs in Non-Hodgkin´s Lymphomas

Journal: Current Angiogenesis (Discontinued)
Volume: 1,Issue: 1
Page: 20-25
Authors: Natalia Morais Borges and Gisele W.B. Colleoni

Role of MicroRNAs in B Cell Leukemias and Lymphomas

Journal: Current Molecular Medicine
Volume: 14,Issue: 5
Page: 580-597
Authors: A. Schmidt and R. Kuppers

Hepatitis C Virus-Associated B-Cell Non-Hodgkin's Lymphoma: Clinical and Therapeutic Challenges

Journal: Current Drug Targets
Volume: 18,Issue: 7
Page: 766-771
Authors: Sabino Russi, Loredana Sansonno and Domenico Sansonno

Non-Hodgkins Lymphoma: Review of Conventional Treatments

Journal: Current Pharmaceutical Biotechnology
Volume: 2,Issue: 4
Page: 279-291
Authors: P. Multani, C.A. White and A. Grillo-Lopez

New Targets of Therapy in T-Cell Lymphomas

Journal: Current Drug Targets
Volume: 11,Issue: 4
Page: 482-493
Authors: Jack Erter, Lapo Alinari, Kamruz Darabi, Metin Gurcan, Ramiro Garzon, Guido Marcucci, Mark A. Bechtel, Henry Wong and Pierluigi Porcu

Synthesis and Comparison of the Antitumor Activities of Steroids on ABCB1-transfected Mouse Lymphoma and Human Ovary Carcinoma

Journal: Letters in Drug Design & Discovery
Volume: 8,Issue: 2
Page: 138-147
Authors: Julianna Serly, Iren Vincze, Csaba Somlai, Laszlo Hodoniczki and Jozsef Molnar

Biodistribution and Dosimetry of 177Lu-tetulomab, a New Radioimmunoconjugate for Treatment of Non-Hodgkin Lymphoma

Journal: Current Radiopharmaceuticals
Volume: 6,Issue: 1
Page: 20-27
Authors: Ada H. V. Repetto-Llamazares, Roy H. Larsen, Camilla Mollatt, Michael Lassmann and Jostein Dahle

The Role of CXC-Chemokine IL-8, IL-6 and CXCR2 Receptor in Lymphoplasmacytic Lymphoma: Correlations with Microvascular Characteristics and Clinical Features

Journal: Current Angiogenesis (Discontinued)
Volume: 2,Issue: 2
Page: 110-118
Authors: Georgia Levidou, Tatiana Tzenou, Marie-Christine Kyrtsonis, Eftychia Nikolaou, Nikolaos Kavantzas, Dimitris Maltezas, Katerina Xirokosta, Efstathios Koulieris, Athanasia Sepsa, Katerina Bitsanis, Ilias Pessach, Vassiliki Bartzis, Maria Dimou, Panayiotis Panayiotidis, Gerassimos A Pangalis, Efstratios Patsouris and Penelope Korkolopoulou

Tumor-selective Cytotoxicity of a Novel Pentadiene Analogue on Human Leukemia/lymphoma Cells

Journal: Clinical Cancer Drugs
Volume: 3,Issue: 2
Page: 138-146
Authors: Yahaira Santiago-Vázquez, Umashankar Das, Armando Varela-Ramirez, Sarah T. Baca, Yoshira Ayala-Marin, Carolina Lema, Swagatika Das, Alaa Baryyan, Jonathan R. Dimmock and Renato J. Aguilera

Radioimmunotherapy of Non-Hodgkins Lymphomas

Journal: Current Drug Targets
Volume: 7,Issue: 10
Page: 1293-1300
Authors: Bruce D. Cheson

mTOR as a Target of Everolimus in Refractory/Relapsed Hodgkin Lymphoma

Journal: Current Medicinal Chemistry
Volume: 19,Issue: 7
Page: 945-954
Authors: A. Guarini, C. Minoia, M. Giannoccaro, A. Rana, A. Iacobazzi, A. Lapietra, A. Raimondi, N. Silvestris, C. D. Gadaleta and G. Ranieri

Transcription Factor Profiling Shows New Ways Towards New Treatment Options of Cutaneous T cell lymphomas

Journal: Current Drug Discovery Technologies
Volume: 4,Issue: 1
Page: 24-30
Authors: Udo Dobbeling

Viral Latent Proteins as Targets for Kaposis Sarcoma and Kaposis Sarcoma-associated Herpesvirus (KSHV / HHV-8) Induced Lymphoma

Journal: Current Drug Target -Infectious Disorders
Volume: 3,Issue: 2
Page: 129-135
Authors: Michelle R. Staudt and Dirk P. Dittmer

A Phosphoproteomics Approach to Identify Candidate Kinase Inhibitor Pathway Targets in Lymphoma-Like Primary Cell Lines

Journal: Current Drug Discovery Technologies
Volume: 10,Issue: 4
Page: 283-304
Authors: Miliana Vojvodic, Loen M. Hansford, Olena Morozova, Kim M. Blakely, Paul Taylor, Kelly E. Fathers, Jason Moffat, Marco Marra, Kristen M. Smith, Michael F. Moran and David R. Kaplan

TP73, An Under-Appreciated Player in Non-Hodgkin Lymphoma Pathogenesis and Management

Journal: Current Molecular Medicine
Volume: 14,Issue: 4
Page: 432-439
Authors: H.M. Hassan, B.J. Dave and R.K. Singh

Deregulated Expression of miR-224 and its Target Gene: CD59 Predicts Outcome of Diffuse Large B-cell Lymphoma Patients Treated with R-CHOP

Journal: Current Cancer Drug Targets
Volume: 14,Issue: 7
Page: 659-670
Authors: Guoqi Song, Guorong Song, Huiyun Ni, Ling Gu, Hong Liu, Baoan Chen, Bangshun He, Yuqin Pan, Shukui Wang and William C. Cho

Anaplastic Lymphoma Kinase Inhibitors in Non-Small Cell Lung Cancer

Journal: Current Drug Targets
Volume: 17,Issue: 6
Page: 739-745
Authors: David M. Straughan, Sa d C. Azoury and Vivek Shukla

Recent Development in the Discovery of Anaplastic Lymphoma Kinase (ALK) Inhibitors for Non-small Cell Lung Cancer

Journal: Current Medicinal Chemistry
Volume: 24,Issue: 6
Page: 590-613
Authors: Jingru Liu and Shutao Ma

Allogeneic Hematopoietic Stem Cell Transplantation in Relapsed/ Refractory Diffuse Large B Cell Lymphoma

Journal: Current Stem Cell Research & Therapy
Volume: 12,Issue: 1
Page: 14-18
Authors: Zhengrui Xiao, Jianyong Li and Kourong Miao

Prospecting for New Inhibitors of Anaplastic Lymphoma Kinase, A Clinically Relevant Oncogenic Drug Target

Journal: Current Bioactive Compounds
Volume: 13,Issue: 3
Page: 236-243
Authors: Daniel F. Kawano, Carlton A. Taft and Carlos H.T.P. da Silva

The Life Cycle of Cutaneous T Cell Lymphoma Reveals Opportunities for Targeted Drug Therapy

Journal: Current Cancer Drug Targets
Volume: 4,Issue: 7
Page: 609-619
Authors: Carole L Berger and Richard Edelson

Monoclonal Antibodies: A New Era in the Treatment of Non-Hodgkins Lymphoma

Journal: Current Pharmaceutical Biotechnology
Volume: 2,Issue: 4
Page: 301-311
Authors: A. J. Grillo-Lopez, B.K. Dallaire, A. McClure, R. Weaver, C. Varns, A. Wei, R. Allen, D. Lee, D. Shen, J. Leonard, P.Multani and C.A.White

Human Leukemia and Lymphoma Cell Lines as Models and Resources

Journal: Current Medicinal Chemistry
Volume: 15,Issue: 4
Page: 339-359
Authors: Roderick A.F. MacLeod, Stefan Nagel, Michaela Scherr, Bjorn Schneider, Wilhelm G. Dirks, Cord C. Uphoff, Hilmar Quentmeier and Hans G. Drexler

Beta Caryophyllene and Caryophyllene Oxide, Isolated from Aegle Marmelos, as the Potent Anti-inflammatory Agents against Lymphoma and Neuroblastoma Cells

Journal: Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry
Volume: 13,Issue: 1
Page: 45-55
Authors: Soumyadeep Sain, Pravin K. Naoghare, S. Saravana Devi, Atul Daiwile, K. Krishnamurthi, P. Arrigo and T. Chakrabarti

Metronomic Therapy for Multi Relapsed/Refractory Lymphoma. A Pilot Study

Journal: Current Angiogenesis (Discontinued)
Volume: 2,Issue: 2
Page: 119-125
Authors: Shebli Atrash, Bakhous Aziz, Xenofon Papanikolaou, Abdallah Al-Ola, Muzaffar Jameel, Kumar Surachit, Sarah Waheed, Frits Van Rhee, Saad Z. Usmani and Bart Barlogie

Preliminary Experience with Yttrium-90-labelled Rituximab (Chimeric Anti CD-20 Antibody) in Patients with Relapsed and Refractory B Cell Non-Hodgkins Lymphoma

Journal: Current Radiopharmaceuticals
Volume: 9,Issue: 2
Page: 160-168
Authors: Parul Thakral, Suhas Singla, Atul Vashist, Madhav P. Yadav, Santosh K. Gupta, Jaya S. Tyagi, Atul Sharma, Chandra S. Bal, Snehlata and Arun Malhotra

Vincristine-Induced Seizure Potentiated by Itraconazole Following RCHOP Chemotherapy for Diffuse Large B-Cell Lymphoma

Journal: Current Drug Safety
Volume: 7,Issue: 5
Page: 372-374
Authors: Farzaneh Foroughinia, Shadi Baniasadi, Sharareh Seifi and Fanak Fahimi

Editorial [Hot Topic: Beyond Chemotherapy: Future Directions in Lymphoma Treatment (Guest Editor: Thomas Decker)]

Journal: Current Drug Targets
Volume: 7,Issue: 10
Page: 1291-1291
Authors: Thomas Decker

Genetic Idiotypic and Tumor Cell-Based Vaccine Strategies for Indolent Non Hodgkins Lymphoma

Journal: Current Gene Therapy
Volume: 5,Issue: 5
Page: 511-521
Authors: Pier A. Ruffini, Massimo Di Nicola, Carmelo Carlo-Stella, Salvatore Siena and Alessandro M. Gianni

Zevalin™: 90Yttrium Labeled Anti-CD20 (Ibritumomab Tiuxetan), a New Treatment for Non-Hodgkin ’ s Lymphoma

Journal: Current Pharmaceutical Biotechnology
Volume: 2,Issue: 4
Page: 341-349
Authors: C. Krasner and R.M. Joyce

New Treatment Concepts In Diffuse Large B-Cell Lymphomas (DLBL): Chemotherapy and Biological Therapy

Journal: Reviews on Recent Clinical Trials
Volume: 2,Issue: 2
Page: 149-162
Authors: Jose Rodriguez and Antonio Gutierrez

Development and biological studies of 177Lu-DOTA-rituximab for the treatment of Non-Hodgkin’s lymphoma

Journal: Current Radiopharmaceuticals
Volume: 9,Issue: 1
Page: 54-63
Authors: Adriana V.F. Massicano, Priscilla B. Pujatti, Lais F. Alcarde, Miriam F. Suzuki, Patrick J. Spencer and Elaine B. Araújo

Local Treatment for Lymphoid Malignancies of the Eye

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 9,Issue: 10
Page: 1123-1128
Authors: Gian Paolo Giuliari, David M. Hinkle and C. Stephen Foster

VFP: A Visual Algorithm for Predicting Gene Fusion in RNA-Seq Data

Journal: Current Bioinformatics
Volume: 11,Issue: 1
Page: 115-121
Authors: Ye Yang and Juan Liu

Novel Virally Targeted Therapies of EBV-Associated Tumors

Journal: Current Cancer Drug Targets
Volume: 8,Issue: 7
Page: 581-596
Authors: Paolo De Paoli

Malignancy Risk in Systemic Lupus: Recent Research and Ongoing Challenges

Journal: Current Rheumatology Reviews
Volume: 4,Issue: 1
Page: 59-62
Authors: Sasha Bernatsky, Rosalind Ramsey-Goldman and Ann E. Clarke

Lymphoproliferative Lesions in IgG4-Related Disease

Journal: Current Immunology Reviews
Volume: 7,Issue: 2
Page: 221-231
Authors: Wah Cheuk and John K.C. Chan

Immunotherapeutic and Immunoregulatory Drugs in Haematologic Malignancies

Journal: Current Topics in Medicinal Chemistry
Volume: 6,Issue: 16
Page: 1657-1686
Authors: Gerassimos A. Pangalis, Marie-Christine Kyrtsonis, Theodoros P. Vassilakopoulos, Maria N. Dimopoulou, Marina P. Siakantaris, Christos Emmanouilides, Dimitris Doufexis, Sotirios Sahanas, Flora N. Kontopidou, Christina Kalpadakis, Maria K. Angelopoulou, Evangelia M. Dimitriadou, Styliani I. Kokoris and Panayiotis Panayiotidis

Anti-CD30 Human IL-2 Fusion Proteins Display Strong and Specific Cytotoxicity In Vivo

Journal: Current Drug Targets
Volume: 10,Issue: 2
Page: 110-117
Authors: B. Hirsch, J. Brauer, M. Fischdick, C. Loddenkemper, S. Bulfone-Paus, H. Stein and H. Durkop

Recombinant Immunotoxins for the Treatment of Chemoresistant Hematologic Malignancies

Journal: Current Pharmaceutical Design
Volume: 15,Issue: 23
Page: 2652-2664
Authors: Robert J. Kreitman

Immunokinases, a Novel Class of Immunotherapeutics for Targeted Cancer Therapy

Journal: Current Pharmaceutical Design
Volume: 15,Issue: 23
Page: 2693-2699
Authors: Mehmet Kemal Tur, Inga Neef, Gernot Jager, Andreas Teubner, Michael Stocker, Georg Melmer and Stefan Barth

The Acquired Deficiency of C1-Inhibitor: Lymphoproliferation and Angioedema

Journal: Current Molecular Medicine
Volume: 10,Issue: 4
Page: 354-360
Authors: M. Cicardi and A. Zanichelli

Radioimmunotherapy of Solid Tumors: Searching for the Right Target

Journal: Current Drug Delivery
Volume: 8,Issue: 1
Page: 26-44
Authors: Hong Song and George Sgouros

Stem Cell Transplant and Idiotypic Vaccination for B-Cell Malignancies

Journal: Current Topics in Medicinal Chemistry
Volume: 11,Issue: 13
Page: 1653-1660
Authors: Maurizio Bendandi, Fernando Pastor, Jose' Nieto, Elena Soria, Helena Villanueva, Antonia Sampol, Ascension Lopez-Diaz de Cerio and Susana Inoges

Effects of Platinum Nanoparticles on Apoptosis

Journal: Recent Patents on Nanomedicine
Volume: 1,Issue: 2
Page: 162-165
Authors: Yoko Yoshihisa, Mariame Ali Hassan, Takashi Kondo and Tadamichi Shimizu

Intrathecal Rituximab Therapy in Multiple Sclerosis: Review of Evidence Supporting the Need for Future Trials

Journal: Current Drug Targets
Volume: 15,Issue: 13
Page: 1205-1214
Authors: Mickael Bonnan, Sylvie Ferrari, Eric Bertandeau, Stephanie Demasles, Elsa Krim, Marie Miquel and Bruno Barroso

Recent Concise Viewpoints of Chronic Active Epstein-Barr Virus Infection

Journal: Current Pediatric Reviews
Volume: 11,Issue: 1
Page: 5-9
Authors: Motohiko Okano

Eosinophils in Cancer: Favourable or Unfavourable?

Journal: Current Medicinal Chemistry
Volume: 23,Issue: 7
Page: 650-666
Authors: Samy Sakkal, Sarah Miller, Vasso Apostolopoulos and Kulmira Nurgali

Emerging Concepts for the Treatment of Hematological Malignancies with Therapeutic Monoclonal Antibodies

Journal: Current Drug Targets
Volume: 11,Issue: 7
Page: 790-800
Authors: Aude-Helene Capietto, Samarh Keirallah, Emilie Gross, Nicolas Dauguet, Emilie Laprevotte, Christine Jean, Julie Gertner-Dardenne, Christine Bezombes, Anne Quillet-Mary, Mary Poupot, Loic Ysebaert, Guy Laurent and Jean-Jacques Fournie

Leptomeningeal Metastasis: Challenges in Diagnosis and Treatment

Journal: Current Cancer Therapy Reviews
Volume: 7,Issue: 4
Page: 319-327
Authors: Ticiana Leal, Julie E. Chang, Minesh Mehta and H. Ian Robins

Development of a Mimotope-Based Vaccine Against CD20 Antigen

Journal: Protein & Peptide Letters
Volume: 14,Issue: 6
Page: 610-614
Authors: Meng Li, Wei Han, Quiyang Zhang, Xiaochang Xue, Zenglu Wang and Yingqi Zhang

Proteomic Analysis of Mitochondria in Raji Cells Following Exposure to Radiation: Implications for Radiotherapy Response

Journal: Protein & Peptide Letters
Volume: 16,Issue: 11
Page: 1350-1359
Authors: Yujie Jiang, Xin Liu, Xiaosheng Fang and Xin Wang

Structure, Function and Inhibition of Bcl-2 Family Proteins: A New Target for Anti-Tumor Agents

Journal: Mini-Reviews in Medicinal Chemistry
Volume: 9,Issue: 14
Page: 1596-1604
Authors: Guizhi Xiao, Hao Fang, Chengguo Xing and Wenfang Xu

Therapeutic Use of Brentuximab Vedotin in CD30+ Hematologic Malignancies

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 17,Issue: 7
Page: 886-895
Authors: Alberto Fabbri, Emanuele Cencini, Alessandro Gozzetti, Luana Schiattone and Monica Bocchia

Potential Therapeutic Applications of miRNA-Based Technology in Hematological Malignancies

Journal: Current Pharmaceutical Design
Volume: 14,Issue: 21
Page: 2040-2050
Authors: Elisa Barbarotto and George A. Calin

Targeting Cyclooxygenase-2 in Hematological Malignancies: Rationale and Promise

Journal: Current Pharmaceutical Design
Volume: 14,Issue: 21
Page: 2051-2060
Authors: M. P. Bernard, S. Bancos, P. J. Sime and R. P. Phipps

Bortezomib in the Treatment of Cancer

Journal: Recent Patents on Anti-Cancer Drug Discovery
Volume: 1,Issue: 3
Page: 397-403
Authors: Aldo M. Roccaro, Angelo Vacca and Domenico Ribatti

Gallium in Cancer Treatment

Journal: Current Topics in Medicinal Chemistry
Volume: 4,Issue: 15
Page: 1575-1583
Authors: Michael A. Jakupec and Bernhard K. Keppler

Revising Skin Cancers by Means of Epigenetic Markers

Journal: Recent Patents on Biomarkers
Volume: 2,Issue: 2
Page: 93-98
Authors: Carolina Constantin and Sabina A. Zurac

Changes in Glutathione, Oxidative Stress and Mitochondrial Membrane Potential in Apoptosis Involving the Anticancer Activity of Cantharidin Isolated from Redheaded Blister Beetles, Epicauta hirticornis

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 13,Issue: 7
Page: 1096-1114
Authors: Akalesh Kumar Verma and Surya Bali Prasad

HPMA Copolymer-Bound Doxorubicin Induces Immunogenic Tumor Cell Death

Journal: Current Medicinal Chemistry
Volume: 20,Issue: 38
Page: 4815-4826
Authors: M. Sirova, M. Kabesova, L. Kovar, T. Etrych, J. Strohalm, K. Ulbrich and B. Rihova

Clinical Immunotherapy of B-Cell Malignancy Using CD19-Targeted CAR T-Cells

Journal: Current Gene Therapy
Volume: 14,Issue: 1
Page: 35-43
Authors: John Maher

Non-squamous Tumors of the Oropharynx and Oral Cavity: CT and MR Imaging Findings with Clinical- Pathologic Correlation

Journal: Current Medical Imaging Reviews
Volume: 13,Issue: 2
Page: 166-175
Authors: Antonello Vidiri, Davide Curione, Francesca Piludu, Antonino Guerrisi, Barbara Pichi, Giuseppe Mercante, Paolo Marchesi, Valentina Manciocco, Giuseppe Spriano and Renato Covello

Therapeutic Targeting of Apoptotic Pathways in Cancer

Journal: Current Drug Targets
Volume: 7,Issue: 10
Page: 1361-1369
Authors: Johannes Meiler and Martin Schuler

Imiquimod

Journal: Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry
Volume: 6,Issue: 3
Page: 228-236
Authors: Idil Unal and Ilgen Ertam

Protein Kinase CK2 Inhibitors: Emerging Anticancer Therapeutic Agents?

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 8,Issue: 7
Page: 798-806
Authors: Andrea Bortolato, Giorgio Cozza and Stefano Moro

Staging of Breast Cancer with 18F-FDG PET and PET/CT

Journal: Current Medical Imaging Reviews
Volume: 5,Issue: 4
Page: 203-209
Authors: Emiel J.T. Rutgers, Wouter V. Vogel and Renato A. Valdes Olmos

Interferon Therapy for Malignant Solid Tumors

Journal: Current Drug Therapy
Volume: 5,Issue: 2
Page: 132-138
Authors: Katherine E. Warren and Howard A. Young

The Ubiquitin-Proteasome System (UPS) and the Mechanism of Action of Bortezomib

Journal: Current Pharmaceutical Design
Volume: 17,Issue: 15
Page: 1483-1499
Authors: Boris Cvek and Zdenek Dvorak

BCL-2 Family Proteins: The Mitochondrial Apoptotic Key Regulators

Journal: Current Cancer Therapy Reviews
Volume: 8,Issue: 2
Page: 133-140
Authors: P. Daisy and K. Saipriya

Dissecting Bortezomib: Development, Application, Adverse Effects and Future Direction

Journal: Current Pharmaceutical Design
Volume: 19,Issue: 18
Page: 3190-3200
Authors: Biyin Cao, Jie Li and Xinliang Mao

Pixuvri® (Pixantrone Dimaleate, BBR 2778): From Lab to Market

Journal: Current Organic Chemistry
Volume: 19,Issue: 10
Page: 886-897
Authors: A. Paul Krapcho

Five Pediatric Cancers – Update on Genetic Implications

Journal: Current Pediatric Reviews
Volume: 13,Issue: 1
Page: 42-48
Authors: Stacy Cooper, Jeffrey Rubens and Joann Bodurtha

Targeted Therapy Towards Cancer-A Perspective

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 17,Issue: 3
Page: 311-317
Authors: Sean L. Kitson, Vincenzo Cuccurullo, Andrea Ciarmiello and Luigi Mansi

Immunotoxins in the Treatment of Hematologic Malignancies

Journal: Current Drug Targets
Volume: 7,Issue: 10
Page: 1301-1311
Authors: Robert J. Kreitman and Ira Pastan

EBV-Associated Tumors: Pathogenetic Insights for Improved Disease Monitoring and Treatment

Journal: Current Cancer Therapy Reviews
Volume: 1,Issue: 1
Page: 27-44
Authors: Riccardo Dolcetti, Massimo Guidoboni, Annunziata Gloghini and Antonino Carbone

Idiotype Vaccines for Human B-Cell Malignancies

Journal: Current Pharmaceutical Design
Volume: 16,Issue: 3
Page: 300-307
Authors: S. Inoges, A. Lopez-Diaz de Cerio, E. Soria, H. Villanueva, F. Pastor and M. Bendandi

Marizomib, a Proteasome Inhibitor for All Seasons: Preclinical Profile and a Framework for Clinical Trials

Journal: Current Cancer Drug Targets
Volume: 11,Issue: 3
Page: 254-284
Authors: B. C. Potts, M. X. Albitar, K. C. Anderson, S. Baritaki, C. Berkers, B. Bonavida, J. Chandra, D. Chauhan, J. C. Cusack, W. Fenical, I. M. Ghobrial, M. Groll, P. R. Jensen, K. S. Lam, G. K. Lloyd, W. McBride, D. J. McConkey, C. P. Miller, S. T.C. Neuteboom, Y. Oki, H. Ovaa, F. Pajonk, P. G. Richardson, A. M. Roccaro, C. M. Sloss, M. A. Spear, E. Valashi, A. Younes and M. A. Palladino

Molecular Functions of BCL10 and MALT1 in Normal and Neoplastic Lymphocytes

Journal: Current Immunology Reviews
Volume: 1,Issue: 3
Page: 287-296
Authors: Jurgen Ruland

B Lymphocyte Memory in X-Linked Lymphoproliferative Disease (XLP)

Journal: Current Immunology Reviews
Volume: 6,Issue: 4
Page: 323-328
Authors: Ana Coraglia, Liliana Belmonte, Cecilia Parodi, Mariela Baston, Patricia Bare, Beatriz Ruibal-Ares, N. Galassi and Maria M.E. de Bracco

Viral and Cellular Cytokines as Therapeutic Targets in AIDS-Related Lymphoproliferative Disorders

Journal: Current Drug Target -Cardiovascular & Hematological Disorders
Volume: 3,Issue: 1
Page: 81-96
Authors: Yoshiyasu Aoki and Giovanna Tosato

The Nuclear Orphan Receptor NR4A1 and NR4A3 as Tumor Suppressors in Hematologic Neoplasms

Journal: Current Drug Targets
Volume: 16,Issue: 1
Page: 38-46
Authors: Kerstin Wenzl, Katharina Troppan, Peter Neumeister and Alexander J.A. Deutsch

High Incidence of Infections in HIV-positive Patients Treated for Lymphoproliferative Disorders

Journal: Current HIV Research
Volume: 15,Issue: 4
Page: 258-265
Authors: Andrea Calcagno , Anna Lucchini , Daniele Caracciolo, Rosanna Balbiano, Margherita Bracchi , Francesca Sordella, Giovanna Gregori , Filippo Lipani , Sabrina Audagnotto, Monica Chiriotto , Giovanni Cavaglià , Valeria Ghisetti, Giovanni Di Perri and Stefano Bonora

Proteasome Inhibition as a New Therapeutic Principle in Hematological Malignancies

Journal: Current Drug Targets
Volume: 7,Issue: 10
Page: 1341-1347
Authors: Constantine S. Mitsiades, Nicholas Mitsiades, Teru Hideshima, Paul G. Richardson and Kenneth C. Anderson

Radionuclide Therapy of Cancer with Radiolabeled Antibodies

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 7,Issue: 3
Page: 335-343
Authors: Wim J. Oyen, E. J. Postema, Frans H. Corstens, Otto C. Boerman and Manuel J. Koppe

Genetic Vaccination for the Immunotherapy of B-Cell Malignancies

Journal: Current Gene Therapy
Volume: 2,Issue: 2
Page: 235-242
Authors: F. Benvenuti and O. R. Burrone

Radioimmunotherapy of Cancer Using Monoclonal Antibodies to Target Radiotherapy

Journal: Current Pharmaceutical Design
Volume: 6,Issue: 14
Page: 1399-1418
Authors: Timothy M. Illidge and Susannah Brock

Novel Epigenetic Targets in Lymphoproliferative Disorders

Journal: Current Cancer Drug Targets
Volume: 8,Issue: 5
Page: 378-391
Authors: Julio Delgado

A Combined Approach with Rituximab Plus Anti-TRAIL-R Agonistic Antibodies for the Treatment of Haematological Malignancies

Journal: Current Pharmaceutical Design
Volume: 14,Issue: 21
Page: 2085-2099
Authors: Silvia Sancilio, Vittorio Grill and Roberta Di Pietro

Anti-TNF and Crohns Disease: When Should we Start?

Journal: Current Drug Targets
Volume: 11,Issue: 2
Page: 143-147
Authors: H. H. Fidder and D. W. Hommes

Concomitant Use of Immunomodulators with Anti-TNF in Crohns Disease: Yes or No?

Journal: Current Drug Targets
Volume: 11,Issue: 2
Page: 176-178
Authors: Johannes Meier and Andreas Sturm

The mTOR Pathway: A New Target in Cancer Therapy

Journal: Current Cancer Drug Targets
Volume: 10,Issue: 5
Page: 484-495
Authors: L. Ciuffreda, C. Di Sanza, U.C. Incani and M. Milella

A New Twist in Cellular Resistance to the Anticancer Drug Bleomycin-A5

Journal: Current Drug Metabolism
Volume: 11,Issue: 7
Page: 595-602
Authors: Mustapha Aouida and Dindial Ramotar

Epidemiology and Prevention of Bacterial Infections in Patients with Hematologic Malignancies

Journal: Infectious Disorders - Drug Targets
Volume: 11,Issue: 1
Page: 11-17
Authors: Jeffrey Tessier and Costi D. Sifri

The Therapeutic Potential of Gallium-Based Complexes in Anti-Tumor Drug Design

Journal: Letters in Drug Design & Discovery
Volume: 4,Issue: 5
Page: 311-317
Authors: Michael Frezza, Claudio N. Verani, Di Chen and Q. Ping Dou

Pharmacokinetic Properties of Rituximab

Journal: Reviews on Recent Clinical Trials
Volume: 3,Issue: 1
Page: 22-30
Authors: Jose Rodriguez and Antonio Gutierrez

Clinical Trials of Targeted Alpha Therapy for Cancer

Journal: Reviews on Recent Clinical Trials
Volume: 3,Issue: 3
Page: 185-191
Authors: Barry J. Allen

Epstein-Barr Virus Infection and its Pathogenetic Roles for Human Diseases

Journal: Current Pediatric Reviews
Volume: 5,Issue: 4
Page: 192-197
Authors: Motohiko Okano

The ALK Gene, An Attractive Target for Inhibitor Development

Journal: Current Topics in Medicinal Chemistry
Volume: 11,Issue: 11
Page: 1406-1419
Authors: Carmen J. Tartari, Leonardo Scapozza and Carlo Gambacorti-Passerini

Inhibition of Apoptosis in Pediatric Cancer by Survivin

Journal: Current Pediatric Reviews
Volume: 7,Issue: 4
Page: 277-284
Authors: Ayman Samkari and Rachel A. Altura

The Immunoproteasome: An Emerging Therapeutic Target

Journal: Current Topics in Medicinal Chemistry
Volume: 11,Issue: 23
Page: 2923-2930
Authors: Wooin Lee and Kyung Bo Kim

What are the Cancer Risks in BRCA Carriers Apart from Those Regarding the Breast and the Ovary?

Journal: Current Women`s Health Reviews
Volume: 8,Issue: 1
Page: 65-71
Authors: F. Di Gaudio, V. Calo, L. La Paglia, L. Bruno, F. Di Piazza, N. Margarese, F. P. Guadagna, G. Guarneri, G. Cicero, G. R. Ricciardi, C. Rolfo Cervetto, G. Cucinella, G. Pantuso, V. Bazan and A. Russo

Synthetic Retinoids and Their Nuclear Receptors

Journal: Current Medicinal Chemistry-Anti-Cancer Agents
Volume: 4,Issue: 3
Page: 199-230
Authors: M. I. Dawson

Novel and Emerging Drugs for Acute Myeloid Leukemia

Journal: Current Cancer Drug Targets
Volume: 12,Issue: 5
Page: 522-530
Authors: E. M. Stein and M. S. Tallman

Primary Sjogren’s Syndrome: Time for Prospective Cohorts

Journal: Current Pharmaceutical Biotechnology
Volume: 13,Issue: 10
Page: 2022-2025
Authors: Jacques-Eric Gottenberg and Xavier Mariette

Computational Modeling and Simulation of the Bcl-2 Family: Paving the Way for Rational Drug Design

Journal: Current Medicinal Chemistry
Volume: 19,Issue: 36
Page: 6081-6094
Authors: J. L. Rosas-Trigueros, I. Ilizaliturri-Flores, C. G. Benitez-Cardoza, J. Correa-Basurto and A. Zamorano-Carrillo

Shedding Light on Serum Vitamin D Concentrations and the Risk of Rarer Cancers

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 13,Issue: 1
Page: 65-69
Authors: Kathy J. Helzlsouer and Lisa Gallicchio

Advances in the Management of Malignant Hemopathies: The Role of Statins

Journal: Recent Patents on DNA & Gene Sequences (DIscontinued)
Volume: 7,Issue: 1
Page: 57-61
Authors: Romeo-Gabriel Mihaila

Renal Cell Carcinoma in a Patient with Rheumatoid Arthritis Treated with Adalimumab

Journal: Current Drug Safety
Volume: 9,Issue: 1
Page: 69-72
Authors: Senol Kobak, Ahmet Karaarslan and Yunus Aktakka

MET and ALK as Targets for the Treatment of NSCLC

Journal: Current Pharmaceutical Design
Volume: 20,Issue: 24
Page: 3914-3932
Authors: Capelletti M, Gelsomino F. and Tiseo M.

Could Resveratrol be a Useful Drug for the Treatment of Malignant Hemopathies?

Journal: Recent Patents on Anti-Cancer Drug Discovery
Volume: 9,Issue: 3
Page: 340-353
Authors: Romeo G. Mihaila

Nuclear Factor-κB: A Holy Grail in Cancer Prevention and Therapy

Journal: Current Signal Transduction Therapy
Volume: 1,Issue: 1
Page: 25-52
Authors: Bharat B. Aggarwal, Gautam Sethi, Asha Nair and Haruyo Ichikawa

Current status of Immunotherapy in B Cell Malignancies

Journal: Current Drug Targets
Volume: 7,Issue: 10
Page: 1371-1374
Authors: D. M. Kofler, C. Mayr and C.-M. Wendtner

Pharmacological Strategies to Increase the Antitumor Activity of Methylating Agents

Journal: Current Medicinal Chemistry
Volume: 9,Issue: 13
Page: 1285-1301
Authors: Lucio Tentori and Grazia Graziani

Strategy for Treatment of Helicobacter pylori Infection in Adults I. Updated Indications for Test and Eradication Therapy Suggested in 2000

Journal: Current Pharmaceutical Design
Volume: 6,Issue: 15
Page: 1503-1514
Authors: Shigemi Nakajima, David Y. Graham, Takanori Hattori and Tadao Bamba

Use of Analogs of Peptide Hormones Conjugated to Cytotoxic Radicals for Chemotherapy Targeted to Receptors on Tumors

Journal: Current Drug Delivery
Volume: 8,Issue: 1
Page: 11-25
Authors: Andrew V. Schally, Jorg B. Engel, Gunter Emons, Norman L. Block and Jacek Pinski

Inhibitors of Apoptosis Proteins (IAPs) as Potential Molecular Targets for Therapy of Hematological Malignancies

Journal: Current Molecular Medicine
Volume: 11,Issue: 8
Page: 633-649
Authors: P. Smolewski and T. Robak

Forodesine (BCX-1777, Immucillin H) - A New Purine Nucleoside Analogue: Mechanism of Action and Potential Clinical Application

Journal: Mini-Reviews in Medicinal Chemistry
Volume: 7,Issue: 9
Page: 976-983
Authors: Anna Korycka, Jerzy Z. Blonski and Tadeusz Robak

dUTPase in Human Neoplastic Cells as a Potential Target for Therapeutic Intervention

Journal: Current Protein & Peptide Science
Volume: 2,Issue: 4
Page: 349-360
Authors: Friedrich A. Grasser, Bernd F.M. Romeike, Gerald Niedobitek, John Nicholls and Elisabeth Kremmer

Novel Purine Nucleoside Analogues for Hematological Malignancies

Journal: Recent Patents on Anti-Cancer Drug Discovery
Volume: 3,Issue: 2
Page: 123-136
Authors: Anna Korycka, Ewa Lech-Maranda and Tadeusz Robak

Is there a Benefit from the Concomitant Use of Immunosupression with Anti-TNF in Crohns Disease; Heads or Tails?

Journal: Reviews on Recent Clinical Trials
Volume: 4,Issue: 3
Page: 152-158
Authors: Peter Laszlo Lakatos

Promising Activity of Mammalian Target of Rapamycin Inhibitors in Hematologic Malignancies Therapy

Journal: Current Signal Transduction Therapy
Volume: 6,Issue: 1
Page: 44-54
Authors: Ota Fuchs

The Evolving Therapeutic Approaches for Epstein-Barr Virus Infection in Immunocompetent and Immunocompromised Individuals

Journal: Current Drug Target - Immune, Endocrine & Metabolic Disorders
Volume: 3,Issue: 2
Page: 137-142
Authors: Motohiko Okano

Recombinant Adenovirus-mediated Cytotoxic Gene Therapy and Lymphoproliferative Disorders: Analysis Based on Pharmacodynamics

Journal: Current Drug Target - Immune, Endocrine & Metabolic Disorders
Volume: 2,Issue: 2
Page: 109-118
Authors: Francesco Turturro

Current Concepts and Future Directions in Radioimmunotherapy

Journal: Current Drug Discovery Technologies
Volume: 7,Issue: 4
Page: 253-262
Authors: Frank I. Lin and Andrei Iagaru

Update on Evidence that Support a Role of Solar Ultraviolet-B Irradiance in Reducing Cancer Risk

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 13,Issue: 1
Page: 140-146
Authors: William B. Grant

The Role of microRNAs in the Pathogenesis and Treatment of Hematopoietic Malignancies

Journal: Current Pharmaceutical Design
Volume: 19,Issue: 7
Page: 1201-1210
Authors: Corina A. Schmid, Vanessa J. Craig, Anne Muller and Michael Flori

Expression and Function of the Transient Receptor Potential Ion Channel Family in the Hematologic Malignancies

Journal: Current Molecular Pharmacology
Volume: 6,Issue: 3
Page: 137-148
Authors: Maria B. Morelli, Sonia Liberati, Consuelo Amantini, Massimo Nabiss, Matteo Santoni, Valerio Farfariello and Giorgio Santoni

Potent New Weapons in the Oncology Arsenal (Antibody-Drug Conjugates) Require Unique Biological Manufacturing Expertise

Journal: Current Organic Chemistry
Volume: 18,Issue: 8
Page: 1020-1027
Authors: Thomas Rohrer

Current Strategies to Overcome Resistance to ALK-Inhibitor Agents

Journal: Current Drug Metabolism
Volume: 16,Issue: 7
Page: 585-596
Authors: Francesca Simionato, Melissa Frizziero, Carmine Carbone, Giampaolo Tortora and Davide Melisi

EBV-Related Malignancies, Outcomes and Novel Prevention Strategies

Journal: Infectious Disorders - Drug Targets
Volume: 16,Issue: 1
Page: 4-21
Authors: Oluwatobi Ohiole Ozoya, Lubomir Sokol and Samir Dalia

Challenges and Strategies in Precision Medicine for Non-Small-Cell Lung Cancer

Journal: Current Pharmaceutical Design
Volume: 22,Issue: 28
Page: 4374-4385
Authors: Joseph J. Sacco, Hussein Al-Akhrass and Cornelia M. Wilson

Cordycepin Affects Multiple Apoptotic Pathways to Mediate Hepatocellular Carcinoma Cell Death

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 17,Issue: 1
Page: 143-149
Authors: Yulin Zhou, Zhihua Guo, Qingfan Meng, Jiahui Lu, Ning Wang, Hui Liu, Qiming Liang, Yutong Quan, Di Wang and Jing Xie

HCV-Related Transformation and New Therapeutic Strategies: An Update

Journal: Current Cancer Therapy Reviews
Volume: 2,Issue: 1
Page: 41-56
Authors: Clara Balsano and Anna Alisi

Inhibition of Multidrug Resistance of Cancer Cells by Natural Diterpenes, Triterpenes and Carotenoids

Journal: Current Pharmaceutical Design
Volume: 12,Issue: 3
Page: 287-311
Authors: Joseph Molnar, Nora Gyemant, Masaru Tanaka, Judith Hohmann, Elke Bergmann-Leitner, Peter Molnar, Joseph Deli, Remigijus Didiziapetris and Maria J. U. Ferreira

New Treatment Strategies for Multiple Myeloma by Targeting BCL-2 and the Mevalonate Pathway

Journal: Current Pharmaceutical Design
Volume: 12,Issue: 3
Page: 327-340
Authors: Niels W.C.J. van de Donk, Andries C. Bloem, Ellen v. d. Spek and Henk M. Lokhorst

Interleukin-10

Journal: Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry
Volume: 5,Issue: 3
Page: 223-231
Authors: K. Asadullah, R. Sabat, M. Friedrich, W. D. Docke, H. D. Volk and W. Sterry

Recent Clinical Trials of Cladribine in Hematological Malignancies and Autoimmune Disorders

Journal: Reviews on Recent Clinical Trials
Volume: 1,Issue: 1
Page: 15-34
Authors: Tadeusz Robak, Agnieszka Wierzbowska and Ewa Robak

Clinical Benefit of Idiotype Vaccines: Too Many Trials for a Clever Demonstration?

Journal: Reviews on Recent Clinical Trials
Volume: 1,Issue: 1
Page: 67-74
Authors: Maurizio Bendandi

Focal Adhesion Kinase as a Therapeutic Target of Bortezomib

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 10,Issue: 10
Page: 747-752
Authors: Bor-Sheng Ko, Tzu-Ching Chang and Jun-Yang Liou

Update on Anti-TNF-Alpha Treatment in Rheumatic Diseases

Journal: Current Drug Therapy
Volume: 1,Issue: 3
Page: 311-318
Authors: Marco Massarotti, Antonella Ferrara and Bianca Marasini

B-lymphocytes as Targets for Therapy in Chronic Cold Agglutinin Disease

Journal: Cardiovascular & Hematological Disorders-Drug Targets
Volume: 7,Issue: 3
Page: 219-227
Authors: Sigbjorn Berentsen, Elling Ulvestad and Geir E. Tjonnfjord

Methodological Aspects and Applications of In Vivo Imaging of Apoptosis in Oncology: An Illustrative Review

Journal: Current Medical Imaging Reviews
Volume: 1,Issue: 3
Page: 221-228
Authors: Marina S. Kartachova, Marcel Verheij, Cornelis A. Hoefnagel, Berthe L. van Eck and Renato A. Valdes Olmos

Drug Delivery Strategies for the Treatment of Helicobacter pylori Infections

Journal: Current Pharmaceutical Design
Volume: 11,Issue: 6
Page: 775-790
Authors: B. R. Conway

Kinases as Drug Discovery Targets in Hematologic Malignancies

Journal: Current Molecular Medicine
Volume: 5,Issue: 7
Page: 625-642
Authors: A. L. Hannah

Current Strategies to Target the Anti-Apoptotic Bcl-2 Protein in Cancer Cells

Journal: Current Medicinal Chemistry
Volume: 11,Issue: 8
Page: 1031-1040
Authors: Sara M.E. Oxford, Claire L. Dallman, Peter W.M. Johnson, A. Ganesan and Graham Packham

Antiangiogenic Therapy in Hematologic Malignancies

Journal: Current Pharmaceutical Design
Volume: 10,Issue: 11
Page: 1221-1234
Authors: Moehler T. M., Hillengass J., Goldschmidt H. and Ho A. D.

Etoposide: Discovery and Medicinal Chemistry

Journal: Current Medicinal Chemistry
Volume: 11,Issue: 18
Page: 2443-2466
Authors: Philippe Meresse, Elsa Dechaux, Claude Monneret and Emmanuel Bertounesque

A Review of Depsipeptide and Other Histone Deacetylase Inhibitors in Clinical Trials

Journal: Current Pharmaceutical Design
Volume: 10,Issue: 19
Page: 2289-2298
Authors: Richard Piekarz and Susan Bates

Autoimmune Lymphoproliferative Syndrome (ALPS)

Journal: Current Pharmaceutical Design
Volume: 9,Issue: 3
Page: 265-278
Authors: Jack J.H. Bleesing

Radioimmunotherapy of B-Cell NHL

Journal: Current Pharmaceutical Biotechnology
Volume: 2,Issue: 4
Page: 327-339
Authors: R.F. Meredith and S.J. Knox

Photochemotherapy in the Treatment of Cancer

Journal: Current Medicinal Chemistry
Volume: 8,Issue: 12
Page: 1405-1418
Authors: Lisa Dalla Via and Sebastiano Marciani Magno

Treatment of Helicobacter pylori Infection in Children

Journal: Current Pharmaceutical Design
Volume: 6,Issue: 15
Page: 1531-1536
Authors: Mark A. Gilger

The α and β Classes Carbonic Anhydrases from Helicobacter pylori as Novel Drug Targets

Journal: Current Pharmaceutical Design
Volume: 14,Issue: 7
Page: 622-630
Authors: Hiroaki Takeuchi, Claudiu T. Supuran, Saburo Onishi and Isao Nishimori

Prognostic Biomarkers of Cutaneous Malignancies – Serological, Immunohistochemical and Proteomic Approaches

Journal: Current Cancer Therapy Reviews
Volume: 4,Issue: 2
Page: 96-104
Authors: Dirk Schadendorf, Jochen Utikal, Balwir Matharoo-Ball, Robert C. Rees and Selma Ugurel

NBS1 Heterozygosity and Cancer Risk

Journal: Current Genomics
Volume: 9,Issue: 4
Page: 275-281
Authors: Alessandra di Masi and Antonio Antoccia

Whos Winning the War? Molecular Mechanisms of Antibiotic Resistance in Helicobacter pylori

Journal: Current Drug Therapy
Volume: 3,Issue: 3
Page: 190-203
Authors: Kathleen R. Jones, Jeong-Heon Cha and D. Scott Merrell

Infection, Stem Cells and Cancer Signals

Journal: Current Pharmaceutical Biotechnology
Volume: 12,Issue: 2
Page: 182-188
Authors: S. Sell

Defining Pharmacokinetics for Individual Patient Dosimetry in Routine Radiopeptide and Radioimmunotherapy of Cancer: Australian Experience

Journal: Current Pharmaceutical Design
Volume: 15,Issue: 9
Page: 966-982
Authors: J. Harvey Turner

Novel Drugs for Chronic Lymphoid Leukemias: Mechanism of Action and Therapeutic Activity

Journal: Current Medicinal Chemistry
Volume: 16,Issue: 18
Page: 2212-2234
Authors: Tadeusz Robak

The PI3K/Akt Pathway as a Target in the Treatment of Hematologic Malignancies

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 9,Issue: 5
Page: 550-559
Authors: Kiyotaka Kawauchi, Toshie Ogasawara, Masako Yasuyama, Kuniaki Otsuka and Osamu Yamada

Proteasome Inhibitors in Cancer Therapy

Journal: Current Drug Targets
Volume: 10,Issue: 10
Page: 968-981
Authors: Ugo Testa

Structure-Function Relationships and Clinical Applications of L-Asparaginases

Journal: Current Medicinal Chemistry
Volume: 17,Issue: 20
Page: 2183-2195
Authors: N.E. Labrou, A.C. Papageorgiou and V.I. Avramis

Monoclonal Antibody Therapy in Haematological Malignancies

Journal: Current Clinical Pharmacology
Volume: 5,Issue: 3
Page: 148-159
Authors: Martine E.D. Chamuleau, Arjan A. van de Loosdrecht and Peter C. Huijgens

Second Generation Proteasome Inhibitors: Carfilzomib and Immunoproteasome-Specific Inhibitors (IPSIs)

Journal: Current Cancer Drug Targets
Volume: 11,Issue: 3
Page: 285-295
Authors: D. J. Kuhn, R. Z. Orlowski and C. C. Bjorklund

Membrane Targeted Chemotherapy with Hybrid Liposomes for Tumor Cells Leading to Apoptosis

Journal: Current Pharmaceutical Design
Volume: 17,Issue: 17
Page: 1709-1719
Authors: Ryuichi Ueoka, Yoko Matsumoto, Koichi Goto, Hideaki Ichihara and Yuji Komizu

Sphingolipid Signaling and Hematopoietic Malignancies: To the Rheostat and Beyond

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 11,Issue: 9
Page: 782-793
Authors: Kenneth C. Loh, Dianna Baldwin and Julie D. Saba

Hypoxia-Inducible Factors and Sphingosine 1-Phosphate Signaling

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 11,Issue: 9
Page: 854-862
Authors: Olivier Cuvillier and Isabelle Ader

Apoptosis Imaging to Monitor Cancer Therapy: The Road to Fast Treatment Evaluation?

Journal: Current Pharmaceutical Biotechnology
Volume: 13,Issue: 4
Page: 571-583
Authors: Marijke De Saint-Hubert, Matthias Bauwens, Alfons Verbruggen and Felix M. Mottaghy

Malignancy and Radiation-Induced Cardiotoxicity

Journal: Cardiovascular & Hematological Disorders-Drug Targets
Volume: 11,Issue: 2
Page: 102-108
Authors: Luigi Mancuso, Andrea Mancuso, Francesca Scordato, Michela Pieri and MC Eliana Valerio

The Pim Kinases: New Targets for Drug Development

Journal: Current Drug Targets
Volume: 12,Issue: 14
Page: 2059-2066
Authors: Ronan Swords, Kevin Kelly, Jennifer Carew, Stefan Nawrocki, Devalingam Mahalingam, John Sarantopoulos, David Bearss and Francis Giles

Protective Effects of Chronic Green Tea Consumption on Age-related Neurodegeneration

Journal: Current Pharmaceutical Design
Volume: 18,Issue: 1
Page: 4-14
Authors: Jose Paulo Andrade and Marco Assuncao

Nelarabine- A New Purine Analog in the Treatment of Hematologic Malignancies

Journal: Reviews on Recent Clinical Trials
Volume: 1,Issue: 3
Page: 185-192
Authors: Sophie Curbo and Anna Karlsson

Molecule of the Month

Journal: Current Topics in Medicinal Chemistry
Volume: 7,Issue: 9
Page: 919-919
Authors: Megan Moore and Craig W. Lindsley

The Anti-Cancer Effect of A3 Adenosine Receptor Agonists: A Novel, Targeted Therapy

Journal: Immunology‚ Endocrine & Metabolic Agents in Medicinal Chemistry
Volume: 7,Issue: 4
Page: 298-303
Authors: P. Fishman, K.A. Jacobson, A. Ochaion, S. Cohen and S. Bar-Yehuda

Influence of CD80 and CD86 Co-Stimulation in the Modulation of the Activation of Antigen Presenting Cells

Journal: Current Immunology Reviews
Volume: 3,Issue: 3
Page: 160-169
Authors: Manzoor A. Mir and Javed N. Agrewala

Use of Radioimmunotherapy in Stem Cell Transplantation and Posttransplantation: Focus on Yttrium 90 Ibritumomab Tiuxetan

Journal: Current Stem Cell Research & Therapy
Volume: 2,Issue: 3
Page: 239-248
Authors: Arturo Molina, Amrita Krishnan, Henry Fung, Ian W. Flinn, David Inwards, Jane N. Winter and Auayporn Nademanee

Cytotoxic and Apoptogenic Activity of a Methanolic Extract from the Marine Invertebrate Ciona intestinalis on Malignant Cell Lines

Journal: Medicinal Chemistry
Volume: 4,Issue: 2
Page: 106-109
Authors: Elisabetta Tosti, Gian Luigi Russo, Gaetano Ciarcia, Emilio Presidente and Rosa Anna Siciliano

Inhibition of Histone Deacetylases: A Pharmacological Approach to the Treatment of Non-Cancer Disorders

Journal: Current Topics in Medicinal Chemistry
Volume: 9,Issue: 3
Page: 257-271
Authors: Norbert L. Wiech, Jed F. Fisher, Paul Helquist and Olaf Wiest

Retinoids as Critical Modulators of Immune Functions: New Therapeutic Perspectives for Old Compounds

Journal: Endocrine, Metabolic & Immune Disorders-Drug Targets
Volume: 9,Issue: 2
Page: 113-131
Authors: Michele Montrone, Debora Martorelli, Antonio Rosato and Riccardo Dolcetti

Monoclonal Antibodies in Rare Acquired Thrombotic Disorders: The Paradigms of Paroxysmal Nocturnal Hemoglobinuria, Thrombotic Thrombocytopenic Purpura and Central Retinal Vein Occlusion

Journal: Current Vascular Pharmacology
Volume: 8,Issue: 1
Page: 51-58
Authors: Panayiotis D. Ziakas, Petros Kopterides and Michael Voulgarelis

Proteasome Inhibitors: Recent Advances and New Perspectives In Medicinal Chemistry

Journal: Current Topics in Medicinal Chemistry
Volume: 10,Issue: 3
Page: 232-256
Authors: E. Genin, M. Reboud-Ravaux and J. Vidal

Histone Deacetylase Inhibitors: Recent Insights from Basic to Clinical Knowledge & Patenting of Anti-Cancer Actions

Journal: Recent Patents on Anti-Cancer Drug Discovery
Volume: 6,Issue: 1
Page: 131-145
Authors: Vincenzo Carafa, Angela Nebbioso and Lucia Altucci

Serine-Threonine Protein Kinases CK1, CK2 and GSK3 in Normal and Malignant Haematopoiesis

Journal: Current Signal Transduction Therapy
Volume: 6,Issue: 1
Page: 88-98
Authors: Francesco Piazza, Sabrina Manni, Anna Colpo, Laura Quotti Tubi, Carmela Gurrieri and Gianpietro Semenzato

An Antifungal Peptide with Antiproliferative Activity Toward Tumor Cells from Red Kidney Beans

Journal: Protein & Peptide Letters
Volume: 18,Issue: 6
Page: 594-600
Authors: Miao Li, Hexiang Wang and Tzi Bun Ng

Expanding Targets for a Metabolic Therapy of Cancer: L-Asparaginase

Journal: Recent Patents on Anti-Cancer Drug Discovery
Volume: 7,Issue: 1
Page: 4-13
Authors: Daniele Covini, Saverio Tardito, Ovidio Bussolati, Laurent R. Chiarelli, Maria V. Pasquetto, Rita Digilio, Giovanna Valentini and Claudia Scotti

Patents on Immunotoxins and Chimeric Toxins for the Treatment of Cancer

Journal: Recent Patents on Drug Delivery & Formulation
Volume: 1,Issue: 2
Page: 105-115
Authors: Christopher Bachran, Mark Sutherland, Diana Bachran and Hendrik Fuchs

An Update on the Other Telomerase Inhibitors: Non-G-Quadruplex Interactive Agent, Non-Antisense, Non-Reverse Transcriptase Telomerase Inhibitors

Journal: Medicinal Chemistry Reviews - Online (Discontinued)
Volume: 2,Issue: 4
Page: 325-343
Authors: L. A. Beltz and K. P. Manfredi

Neoplastic Conditions in the Context of HIV-1 Infection

Journal: Current HIV Research
Volume: 2,Issue: 4
Page: 343-349
Authors: Yoshiyasu Aoki and Giovanna Tosato

The BCL2-Family of Protein Ligands as Cancer Drugs: The Next Generation of Therapeutics

Journal: Current Medicinal Chemistry-Anti-Cancer Agents
Volume: 3,Issue: 3
Page: 217-223
Authors: WenJing Liu, Anca Bulgaru, Missak Haigentz, C. A. Stein, Roman Perez-Soler and Sridhar Mani

The ‘Other’ Telomerase Inhibitors: Non-G-Quadruplex Interactive Agent, Non-Antisense, Non-Reverse Transcriptase Telomerase Inhibitors

Journal: Current Medicinal Chemistry-Anti-Cancer Agents
Volume: 2,Issue: 5
Page: 589-603
Authors: L. A. Beltz

Serum Proteomics in the Diagnosis and Treatment of Haematological Malignancies

Journal: Current Proteomics
Volume: 7,Issue: 3
Page: 195-208
Authors: Sandra Smieszek, Julian Bailes and Mikhail Soloviev

Targeting Bcl-2 Family of Proteins: An Important Strategy in Cancer Therapeutics

Journal: Current Chemical Biology
Volume: 5,Issue: 1
Page: 38-43
Authors: Dinesh T. Makhija, Rakesh R. Somani and Pushkar P. Kalantri

Long-Term Survivors of Cancer in Childhood and Adolescence

Journal: Current Pediatric Reviews
Volume: 8,Issue: 2
Page: 166-178
Authors: Stacey L. Urbach, Sharon Guger and Paul C. Nathan

Yttrium-90 – Current Status, Expected Availability and Applications of a High Beta Energy Emitter

Journal: Current Radiopharmaceuticals
Volume: 5,Issue: 3
Page: 253-263
Authors: R. Leyva Montana, I. Hernandez Gonzalez, A. Alberti Ramirez, L. Garaboldi and M. Chinol

Local Activation and Systemic Dysregulation of T Lymphocytes in Sjögren’s Syndrome

Journal: Current Pharmaceutical Biotechnology
Volume: 13,Issue: 10
Page: 2009-2021
Authors: Robert Busch, Andreas V. Hadjinicolaou and Frances C. Hall

Current and Future Challenges in Primary Sjogren’s Syndrome

Journal: Current Pharmaceutical Biotechnology
Volume: 13,Issue: 10
Page: 2026-2045
Authors: Arjan Vissink, Hendrika Bootsma, Fred KL Spijkervet, Shen Hu, David T Wong and Cees GM Kallenberg

Epigenetics and Sjogren’s Syndrome

Journal: Current Pharmaceutical Biotechnology
Volume: 13,Issue: 10
Page: 2046-2053
Authors: Christelle Le Dantec, Marie-Michele Varin, Wesley H Brooks, Jacques-Olivier Pers, Pierre Youinou and Yves Renaudineau

Paraneoplastic Neurological Syndromes - Diagnosis and Management

Journal: Current Pharmaceutical Design
Volume: 18,Issue: 29
Page: 4518-4525
Authors: Franz Blaes

Susceptibility of Helicobacter pylori to Natural Products: Can Past Research Direct Future Drug Development?

Journal: Current Bioactive Compounds
Volume: 8,Issue: 3
Page: 266-276
Authors: Temitope O. Lawal, Kapil K. Soni, Brian J. Doyle, Bolanle A. Adeniyi and Gail B. Mahady

Chemistry and Pharmacology of Imexon and Related Cyanoaziridines

Journal: Current Medicinal Chemistry
Volume: 19,Issue: 33
Page: 5745-5753
Authors: W.A. Remers and R.T. Dorr

Privileged Scaffolds or Promiscuous Binders: A Glance of Pyrrolo[2,1-f][1,2,4]triazines and Related Bridgehead Nitrogen Heterocycles in Medicinal Chemistry

Journal: Current Pharmaceutical Design
Volume: 19,Issue: 8
Page: 1528-1548
Authors: Yu'ning Song, Peng Zhan, Qingzhu Zhang and Xinyong Liu

Immunomodulatory Effects of Histone Deacetylase Inhibitors

Journal: Current Molecular Medicine
Volume: 13,Issue: 4
Page: 640-647
Authors: P.V. Licciardi, K. Ververis, M.L. Tang, A. El-Osta and T.C. Karagiannis

Targeting the Ubiquitin E1 as a Novel Anti-Cancer Strategy

Journal: Current Pharmaceutical Design
Volume: 19,Issue: 18
Page: 3201-3209
Authors: Wei Xu, Julie L. Lukkarila, Sara R. da Silva, Stacey-Lynn Paiva, Patrick T. Gunning and Aaron D. Schimmer

Deubiquitinating Enzymes as Therapeutic Targets in Cancer

Journal: Current Pharmaceutical Design
Volume: 19,Issue: 22
Page: 4039-4052
Authors: Key-Hwan Lim and Kwang-Hyun Baek

Non-Covalent Proteasome Inhibitors

Journal: Current Pharmaceutical Design
Volume: 19,Issue: 22
Page: 4115-4130
Authors: Julia Kaffy, Guillaume Bernadat and Sandrine Ongeri

New Purine Nucleoside Analogs for Acute Lymphoblastic Leukemia

Journal: Clinical Cancer Drugs
Volume: 1,Issue: 1
Page: 2-10
Authors: Tadeusz Robak

Nature Promises New Anticancer Agents: Interplay with the Apoptosis-related BCL2 Gene Family

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 14,Issue: 3
Page: 375-399
Authors: Maria-Ioanna Christodoulou, Christos K. Kontos, Maria Halabalaki, Alexios-Leandros Skaltsounis and Andreas Scorilas

Radionuclide Antibody-Conjugates, a Targeted Therapy Towards Cancer

Journal: Current Radiopharmaceuticals
Volume: 6,Issue: 2
Page: 57-71
Authors: Sean L. Kitson, Vincenzo Cuccurullo, Thomas S. Moody and Luigi Mansi

HDAC as a Therapeutic Target for Treatment of Endometrial Cancers

Journal: Current Pharmaceutical Design
Volume: 20,Issue: 11
Page: 1847-1856
Authors: Juan Ren, Jia Zhang, Hui Cai, Yi Li, Yuelang Zhang, Xiaozhi Zhang, Dongli Zhao, Zongfang Li, Hongbing Ma, Jiansheng Wang, Yan-e Gao, Lisha Xiao, Rui Liu, Jiansheng Qian, Yan Liu, Hongxia Wei and Jinping Li

Desensitization Protocol for Rituximab-Induced Serum Sickness

Journal: Current Drug Safety
Volume: 9,Issue: 3
Page: 240-242
Authors: Merritt L. Fajt and Andrej A. Petrov

Management of Inflammatory Bowel Disease Patients with a Cancer History

Journal: Current Drug Targets
Volume: 15,Issue: 11
Page: 1042-1048
Authors: Laurent Beaugerie

Antagonists of IAP Proteins: Novel Anti-Tumor Agents

Journal: Current Medicinal Chemistry
Volume: 21,Issue: 34
Page: 3877-3892
Authors: Yichao Wan, Tingting Liu, Xuben Hou, Yanyan Dun, Peng Guan and Hao Fang

5-Aryl-1,3,4-Thiadiazole-Based Hydroxamic Acids as Histone Deacetylase Inhibitors and Antitumor Agents: Synthesis, Bioevaluation and Docking Study

Journal: Medicinal Chemistry
Volume: 11,Issue: 3
Page: 296-304
Authors: Tran Thi Lan Huong, Do Thi Mai Dung, Dao Thi Kim Oanh, Tran Thi Bich Lan, Phan Thi Phuong Dung, Vu Duc Loi, Kyung Rok Kim, Byung Woo Han, Jieun Yun, Jong Soon Kang, Youngsoo Kim, Sang-Bae Han and Nguyen-Hai Nam

Emergence of Azole Therapy for Cancer Associated Fungal Infections and Their Potential Human Toxicity

Journal: The Natural Products Journal
Volume: 4,Issue: 2
Page: 153-158
Authors: Lesley R. Varughese, Sneha Choubey, Mukesh Yadav and Vikas Beniwal

In silico Molecular Interaction Studies of Chiral Heterocyclic Analogs of SAHA as Selective Histone Deacetylase 8 Inhibitors

Journal: Letters in Drug Design & Discovery
Volume: 12,Issue: 9
Page: 711-727
Authors: Appavoo Umamaheswari, Navabshan Irfan and Ayarivan Puratchikody

Targeted Cancer Therapy: The Next Generation of Cancer Treatment

Journal: Current Drug Discovery Technologies
Volume: 12,Issue: 1
Page: 3-20
Authors: Troy A. Baudino

Drug Design Targeting the CXCR4/CXCR7/CXCL12 Pathway

Journal: Current Topics in Medicinal Chemistry
Volume: 16,Issue: 13
Page: 1441-1451
Authors: Dongsheng Xu, Rongshi Li, Jianguo Wu, Li Jiang and Haizhen A. Zhong

Pharmacophore-Based 3D-QSAR Modeling, Virtual Screening and Molecular Docking Analysis for the Detection of MERTK Inhibitors with Novel Scaffold

Journal: Combinatorial Chemistry & High Throughput Screening
Volume: 19,Issue: 1
Page: 73-96
Authors: Suwen Zhou, Lu Zhou, Ruguo Cui, Yahui Tian, Xiaoli Li, Rong You and Liangliang Zhong

Commercially Available, FDA-approved Epigenetic Modifiers As Therapeutic Agents in Bacterial Infection

Journal: Clinical Anti-Inflammatory & Anti-Allergy Drugs
Volume: 2,Issue: 1
Page: 79-88
Authors: Pádraic J. Dunne, Georgia Richard and Joseph Keane

Targeting MDM4 as a Novel Therapeutic Approach for Hematologic Malignancies

Journal: Current Cancer Drug Targets
Volume: 15,Issue: 9
Page: 769-780
Authors: Lei Cao, Lei Fan, Wei Xu and Jian-Yong Li

A New Therapeutic Era in GCB and ABC Diffuse Large B-cell Lymphom a Molecular Subtypes: A Cell of Origin-Driven Review

Journal: Current Cancer Drug Targets
Volume: 16,Issue: 4
Page: 305-322
Authors: Jose D. Sandoval-Sus, Julio Chavez and Samir Dalia

Novel Immunotherapies for Hematological Malignancies

Journal: Current Molecular Pharmacology
Volume: 9,Issue: 3
Page: 264-271
Authors: Monali Vasekar, Syed Rizvi, Xin Liu, Kent E. Vrana and Hong Zheng

Resistance to Crizotinib in Advanced Non-Small Cell Lung Cancer (NSCLC) with ALK Rearrangement: Mechanisms, Treatment Strategies and New Targeted Therapies

Journal: Current Clinical Pharmacology
Volume: 11,Issue: 2
Page: 77-87
Authors: Francesca Casaluce, Assunta Sgambato, Paola Claudia Sacco, Giovanni Palazzolo, Paolo Maione, Antonio Rossi, Fortunato Ciardiello and Cesare Gridelli

Update on Pathogenesis of Sjogren's Syndrome

Journal: Current Rheumatology Reviews
Volume: 13,Issue: 1
Page: 5-22
Authors: Pulukool Sandhya, Biji Theyilamannil Kurien, Debashish Danda and Robert Hal Scofield

Mevalonate Pathway and Human Cancers

Journal: Current Molecular Pharmacology
Volume: 10,Issue: 2
Page: 77-85
Authors: Seyedeh Zahra Bathaie, Mahboobeh Ashrafi, Mahshid Azizian and Fuyuhiko Tamanoi

3D-QSAR and Docking Studies on 2-acyliminobenzimidazoles Derivatives as Potent ALK Inhibitors

Journal: Letters in Drug Design & Discovery
Volume: 12,Issue: 3
Page: 219-233
Authors:

Does Immunohistochemistry Represent a Robust Alternative Technique in Determining Drugable Predictive Gene Alterations in Non-Small Cell Lung Cancer?

Journal: Current Drug Targets
Volume: 18,Issue: 1
Page: 13-26
Authors: Giulio Rossi, Moira Ragazzi, Ione Tamagnini, Maria C. Mengoli, Giada Vincenzi, Fausto Barbieri, Silvia Piccioli, Alessandra Bisagni, Tiziana Vavala, Luisella Righi, Silvia Novello, Francesco Gelsomino and Marcello Tiseo

Hematopoietic Stem Cells Therapies

Journal: Current Stem Cell Research & Therapy
Volume: 12,Issue: 2
Page: 124-133
Authors: Mihaela Chivu-Economescu and Martin Rubach

Studies on Efficacy of a Novel 177Lu-Labeled Porphyrin Derivative in Regression of Tumors in Mouse Model

Journal: Current Radiopharmaceuticals
Volume: 4,Issue: 2
Page: 150-160
Authors: Haladhar D. Sarma, Tapas Das, Sharmila Banerjee, Meera Venkatesh, Pandit B. Vidyasagar and Kaushala P. Mishra

Editorial (Thematic Issue: Advances with microRNAs in Tumorigenesis and Cancer Therapy)

Journal: Current Pharmaceutical Design
Volume: 20,Issue: 33
Page: 5245-5245
Authors: Zhiwei Wang

Treatment of Acute Leukaemias with Monoclonal Antibodies: Current Status and Future Prospects

Journal: Cardiovascular & Hematological Agents in Medicinal Chemistry
Volume: 4,Issue: 1
Page: 33-52
Authors: G. Leone, S. Sica, M. T. Voso, S. Rutella and L. Pagano

Choline Kinase: An Important Target for Cancer

Journal: Current Medicinal Chemistry
Volume: 13,Issue: 10
Page: 1169-1186
Authors: S. Janardhan, P. Srivani and G. N. Sastry

Antagonists of Growth Hormone-Releasing Hormone in Oncology

Journal: Combinatorial Chemistry & High Throughput Screening
Volume: 9,Issue: 3
Page: 163-170
Authors: Andrew V. Schally and Jozsef L. Varga

Design of Peptide-Based Vaccines for Cancer

Journal: Current Medicinal Chemistry
Volume: 13,Issue: 14
Page: 1591-1607
Authors: G. A. Pietersz, D. S. Pouniotis and V. Apostolopoulos

IL-22 and Its Receptors, New Players in the Inflammatory Network

Journal: Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry
Volume: 5,Issue: 3
Page: 251-257
Authors: Laure Dumoutier and Jean-Christophe Renauld

Design of New Oxazaphosphorine Anticancer Drugs

Journal: Current Pharmaceutical Design
Volume: 13,Issue: 9
Page: 963-978
Authors: Jun Liang, Min Huang, Wei Duan, Xue-Qing Yu and Shufeng Zhou

Genetic Modification of Natural Killer Cells for Leukemia Therapies

Journal: Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry
Volume: 6,Issue: 2
Page: 101-108
Authors: Chihaya Imai, Harumi Kakuda, Hiroyuki Fujisaki, Shotaro Iwamoto and Dario Campana

Interferon: Cellular Executioner or White Knight?

Journal: Current Medicinal Chemistry
Volume: 14,Issue: 12
Page: 1279-1289
Authors: S. G. Maher, A. L. Romero-Weaver, A. J. Scarzello and A. M. Gamero

Relation Between Helicobacter Pylori Infection and Gastroduodenal Diseases

Journal: Current Cancer Therapy Reviews
Volume: 3,Issue: 2
Page: 109-115
Authors: Antonio De Luca, Elisabetta Buommino, Lucrezia Manente and Maria A. Tufano

Histone Deacetylase Inhibitors: Molecular and Biological Activity as a Premise to Clinical Application

Journal: Current Drug Metabolism
Volume: 8,Issue: 4
Page: 383-394
Authors: V. Santini, A. Gozzini and G. Ferrari

EGFR Intron Recombination in Human Gliomas: Inappropriate Diversion of V(D)J Recombination?

Journal: Current Genomics
Volume: 8,Issue: 3
Page: 163-170
Authors: Robert A. Fenstermaker and Michael J. Ciesielski

Ruthenium Complex as Enzyme Modulator: Modulation of Lactate Dehydrogenase by a Novel Ruthenium(II) Complex Containing 4-Carboxy N-Ethylbenzamide as a Ligand

Journal: Current Enzyme Inhibition
Volume: 3,Issue: 3
Page: 243-253
Authors: Surendra K. Trigun, Raj K. Koiri, Lallan Mishra, Santosh K. Dubey, Santosh Singh and Pankaj Pandey

Prospects of Embryonic Stem Cells in Treatment of Hematopoietic Disorders

Journal: Current Pharmaceutical Biotechnology
Volume: 8,Issue: 5
Page: 305-317
Authors: Anand S. Srivastava, Rakesh Malhotra, Babak Esmaeli-Azad, Tom Lane and Ewa Carrier

Purine Nucleoside Analogues for the Treatment of Hematological Malignancies: Pharmacology and Clinical Applications

Journal: Current Cancer Drug Targets
Volume: 5,Issue: 6
Page: 421-444
Authors: T. Robak, A. Korycka, M. Kasznicki, A. Wrzesien-Kus and P. Smolewski

Phospholipid Nanosomes

Journal: Current Drug Delivery
Volume: 2,Issue: 4
Page: 329-340
Authors: Trevor P. Castor

Cytochrome P450 Gene Polymorphism and Cancer

Journal: Current Drug Metabolism
Volume: 5,Issue: 3
Page: 211-224
Authors: Jose A.G. Agundez

Changes in the Apoptotic and Survival Signaling in Cancer Cells and Their Potential Therapeutic Implications

Journal: Current Cancer Drug Targets
Volume: 4,Issue: 2
Page: 147-163
Authors: Albert F. Kabore, James B. Johnston and Spencer B. Gibson

Cytokine and Anti-cytokine Therapies for Inflammatory Bowel Disease

Journal: Current Pharmaceutical Design
Volume: 9,Issue: 14
Page: 1107-1113
Authors: Haruhiko Ogata and Toshifumi Hibi

The MYC Oncogene as a Cancer Drug Target

Journal: Current Cancer Drug Targets
Volume: 3,Issue: 3
Page: 163-175
Authors: Heiko Hermeking

CD4+ T Cell Responses in the Immune Control Against Latent Infection by Epstein-Barr Virus

Journal: Current Molecular Medicine
Volume: 3,Issue: 4
Page: 341-347
Authors: Casper Paludan and Christian Munz

Toxin-Labeled Monoclonal Antibodies

Journal: Current Pharmaceutical Biotechnology
Volume: 2,Issue: 4
Page: 313-325
Authors: R.J. Kreitman

Aryltetralin Lignans: Chemistry, Pharmacology and Biotransformations

Journal: Current Medicinal Chemistry
Volume: 8,Issue: 11
Page: 1363-1381
Authors: Bruno Botta, Giulliano Delle Monache, Domenico Misiti, Alberto Vitali and Giovanni Zappia

Structure-Based Design of Novel Anticancer Agents

Journal: Current Cancer Drug Targets
Volume: 1,Issue: 1
Page: 59-71
Authors: F. M. Uckun, E. A. Sudbeck, C. Mao, S. Ghosh, X.-P. Liu, A. O. Vassilev, C. S. Navara and R. K. Narla

Antibiotic-Resistant H. pylori Infection and its Treatment

Journal: Current Pharmaceutical Design
Volume: 6,Issue: 15
Page: 1537-1544
Authors: Waqar A. Qureshi and David Y. Graham

Cell Cycle Molecular Targets in Novel Anticancer Drug Discovery

Journal: Current Pharmaceutical Design
Volume: 6,Issue: 4
Page: 379-392
Authors: John K. Buolamwini

Bcl-2 Antisense in the Treatment of Human Malignancies: A Delusion in Targeted Therapy

Journal: Current Pharmaceutical Biotechnology
Volume: 8,Issue: 6
Page: 373-381
Authors: Bjorn Tore Gjertsen, Therese Bredholt, Nina Anensen and Olav Karsten Vintermyr

IAPs as a Target for Anticancer Therapy

Journal: Current Cancer Drug Targets
Volume: 7,Issue: 8
Page: 785-794
Authors: S. Danson, E. Dean, C. Dive and M. Ranson

ANTI-ADHESION Evolves To a Promising Therapeutic Concept in Oncology

Journal: Current Medicinal Chemistry
Volume: 15,Issue: 10
Page: 978-990
Authors: R. Schmidmaier and P. Baumann

Monoclonal Antibodies in Clinical Oncology

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 8,Issue: 5
Page: 523-532
Authors: S. Dalle, C. Thieblemont, L. Thomas and C. Dumontet

Polymorphisms of Human N-Acetyltransferases and Cancer Risk

Journal: Current Drug Metabolism
Volume: 9,Issue: 6
Page: 520-531
Authors: Jose A.G Agundez

The Role of Mammalian Target of Rapamycin (mTOR) Inhibitors in the Treatment of Solid Tumors

Journal: Current Cancer Therapy Reviews
Volume: 4,Issue: 3
Page: 227-234
Authors: Arun Rajan and Ajeet Gajra

An Update on the Xenograft and Mouse Models Suitable for Investigating New Therapeutic Compounds for the Treatment of B-Cell Malignancies

Journal: Current Pharmaceutical Design
Volume: 14,Issue: 21
Page: 2023-2039
Authors: Paolo Macor, Erika Secco, Sonia Zorzet, Claudio Tripodo, Claudio Celeghini and Francesco Tedesco

Nuclear Medicine: Proof of Principle for Targeted Drugs in Diagnosis and Therapy

Journal: Current Pharmaceutical Design
Volume: 15,Issue: 2
Page: 173-187
Authors: Thomas Leitha

Antiproliferative and Proapoptotic Effects of Proteasome Inhibitors and their Combination with Histone Deacetylase Inhibitors on Leukemia Cells

Journal: Cardiovascular & Hematological Disorders-Drug Targets
Volume: 9,Issue: 1
Page: 62-77
Authors: Ota Fuchs, Dana Provaznikova, Iuri Marinov, Katerina Kuzelova and Ivan Spicka

Helicobacter Pylori and Inflammation

Journal: Current Pharmaceutical Design
Volume: 16,Issue: 38
Page: 4225-4236
Authors: Paolo Ruggiero

Bortezomib as the First Proteasome Inhibitor Anticancer Drug: Current Status and Future Perspectives

Journal: Current Cancer Drug Targets
Volume: 11,Issue: 3
Page: 239-253
Authors: D. Chen, M. Frezza, S. Schmitt, J. Kanwar and Q. P. Dou

SCF E3 Ubiquitin Ligases as Anticancer Targets

Journal: Current Cancer Drug Targets
Volume: 11,Issue: 3
Page: 347-356
Authors: L. Jia and Y. Sun

Lessons to Learn from Crohn's Disease Clinical Trials: Implications for Ulcerative Colitis

Journal: Current Drug Targets
Volume: 12,Issue: 10
Page: 1467-1477
Authors: Aranzazu Jauregui-Amezaga, Elena Ricart and Julian Panes

Pharmacological Characterization of Histone Deacetylase Inhibitor and Tumor Cell-Growth Inhibition Properties of New Benzofuranone Compounds

Journal: Current Cancer Drug Targets
Volume: 11,Issue: 8
Page: 919-928
Authors: C. Blanquart, M. Francois, C. Charrier, P. Bertrand and M. Gregoire

Heart Transplantation for Congenital Heart Disease in the First Year of Life

Journal: Current Cardiology Reviews
Volume: 7,Issue: 2
Page: 72-84
Authors: Richard E. Chinnock and Leonard L. Bailey

Modulating Mesenchymal Stromal Cell Function with Cholesterol Synthesis Inhibitors

Journal: Current Medicinal Chemistry
Volume: 18,Issue: 34
Page: 5196-5205
Authors: A. Poggi and M. R. Zocchi

Potential Clinical Applications of the CXCR4 Antagonist Bicyclam AMD3100

Journal: Mini-Reviews in Medicinal Chemistry
Volume: 5,Issue: 9
Page: 805-824
Authors: Erik De Clercq

Ring-Expanded (“Fat”) Nucleosides as Broad-Spectrum Anticancer and Antiviral Agents

Journal: Current Topics in Medicinal Chemistry
Volume: 2,Issue: 10
Page: 1093-1109
Authors: Ramachandra S. Hosmane

Antibodies Against Complement System in SLE and their Potential Diagnostic Utility

Journal: Current Rheumatology Reviews
Volume: 5,Issue: 1
Page: 58-63
Authors: Pavel Horak, Josef Zadrazil, Hana Ciferska and Zuzana Hermanova

Non-Cancer Uses of Histone Deacetylase Inhibitors: Effects on Infectious Diseases and β-Hemoglobinopathies+

Journal: Current Topics in Medicinal Chemistry
Volume: 9,Issue: 3
Page: 272-291
Authors: Dante Rotili, Giovanna Simonetti, Andrea Savarino, Anna T. Palamara, Anna R. Migliaccio and Antonello Mai

Thromboembolic Complications in Malignant Haematological Disorders

Journal: Current Vascular Pharmacology
Volume: 8,Issue: 4
Page: 482-494
Authors: Roberto Castelli, Barbara Ferrari, Agostino Cortelezzi and Achille Guariglia

Reversal of Multidrug Resistance by Natural Substances from Plants

Journal: Current Topics in Medicinal Chemistry
Volume: 10,Issue: 17
Page: 1757-1768
Authors: Q. Wang, K. Michalak, O. Wesolowska, J. Deli, P. Molnar, J. Hohmann, J. Molnar and H. Engi

IgG4-Related Disease (IgG4+MOLPS) – Diagnostic Criteria and Diagnostic Problems

Journal: Current Immunology Reviews
Volume: 7,Issue: 2
Page: 172-177
Authors: Yasufumi Masaki, Haruka Iwao, Akio Nakajima, Miyuki Miki, Susumu Sugai and Hisanori Umehara

B Cell Depletion with Rituximab in Graves Disease and Associated Orbitopathy

Journal: Immunology‚ Endocrine & Metabolic Agents in Medicinal Chemistry
Volume: 11,Issue: 2
Page: 99-111
Authors: Mario Salvi, Guia Vannucchi and Paolo Beck-Peccoz

Oncogenic Properties of HIV-Tat in Colorectal Cancer Cells

Journal: Current HIV Research
Volume: 5,Issue: 4
Page: 403-409
Authors: Duy Huynh, Elizabeth Vincan, Theo Mantamadiotis, Damian Purcell, Chee-Kai Chan and Robert Ramsay

Advances in Neuroimaging for HIV-1 Associated Neurological Dysfunction: Clues to the Diagnosis, Pathogenesis and Therapeutic Monitoring

Journal: Current HIV Research
Volume: 2,Issue: 1
Page: 61-78
Authors: Michael D. Boska, R. Lee Mosley, Mehmood Nawab, Jay A. Nelson, Marina Zelivyanskaya, Larisa Poluektova, Mariano Ubertia, Huanyu Dou, Travis B. Lewis and Howard E. Gendelman

Targeted Inhibition of Angiogenic Factors in AIDS-related Disorders

Journal: Current Drug Target -Infectious Disorders
Volume: 3,Issue: 2
Page: 115-128
Authors: Yoshiyasu Aoki and Giovanna Tosato

Long-Term Immunovirogical Effect and Tolerability of a Maraviroc- Containing Regimen in Routine Clinical Practice

Journal: Current HIV Research
Volume: 8,Issue: 6
Page: 482-486
Authors: Miguel Genebat, Ezequiel Ruiz-Mateos, Ildefonso Pulido, Alejandro Gonzalez-Serna, Antonio Garcia-Perganeda, Gema Mendez, Maria Concepcion Romero-Sanchez, Sara Ferrando-Martinez and Manuel Leal


The Impact of HAART on HPV-Related Cervical Disease

Journal: Current HIV Research
Volume: 8,Issue: 7
Page: 493-497
Authors: David H. Adler

Human Immunodeficiency Virus-Associated Malignancies: A Therapeutic Update

Journal: Current HIV Research
Volume: 10,Issue: 2
Page: 123-132
Authors: Antonello Malfitano, Giuseppe Barbaro, Alessandro Perretti and Giorgio Barbarini

Targeting mTOR Pathways in Human Malignancies

Journal: Current Pharmaceutical Design
Volume: 18,Issue: 19
Page: 2766-2777
Authors: Angelica Fasolo and Cristiana Sessa

Novel and Emerging Drugs for Chronic Lymphocytic Leukemia

Journal: Current Cancer Drug Targets
Volume: 12,Issue: 5
Page: 471-483
Authors: S. Isfort, P. Cramer and M. Hallek

Novel and Emerging Drugs for Rarer Chronic Lymphoid Leukaemias

Journal: Current Cancer Drug Targets
Volume: 12,Issue: 5
Page: 484-504
Authors: E. Matutes

Novel Therapeutic Approaches to Regulate Human Dihydrofolate Reductase Activity and Expression

Journal: Current Enzyme Inhibition
Volume: 8,Issue: 2
Page: 107-117
Authors: Emine Ercikan Abali, Hilal Celikkaya, Yi-Ching Hsieh, Debabrata Banerjee and Joseph R. Bertino

Synthesis, Docking and Biological Evaluation of Some Novel 5-bromo-2- (5-aryl-1,3,4-thiadiazol-2-yl)isoindoline-1,3-dione Derivatives Targeting ATP-binding Site of Topoisomerase II

Journal: Letters in Drug Design & Discovery
Volume: 9,Issue: 7
Page: 668-675
Authors: Ankur Gupta, Priya Singh, Bhagyashree Kamble, Aditi Kulkarni and Moola Joghee Nanjan Chandrasekar

Ectopic Lymphoid Neogenesis and Lymphoid Chemokines in Sjogren’s Syndrome: At the Interplay between Chronic Inflammation, Autoimmunity and Lymphomagenesis

Journal: Current Pharmaceutical Biotechnology
Volume: 13,Issue: 10
Page: 1989-1996
Authors: Michele Bombardieri and Costantino Pitzalis

Biologic Therapies in Primary Sjögren's Syndrome

Journal: Current Pharmaceutical Biotechnology
Volume: 13,Issue: 10
Page: 1997-2008
Authors: S. J. Bowman

Removal of the Tag from His-tagged ILYd4, a Human CD59 Inhibitor, Significantly Improves its Physical Properties and its Activity

Journal: Current Pharmaceutical Design
Volume: 18,Issue: 27
Page: 4187-4196
Authors: Lin Wu, Sanbao Su, Fengming Liu, Tao Xu, Xiaoxiao Wang, Yan Huang, Xinlu Sun, Xiaowen Ge, Ting Chen, Huixia Liu, Chun Wang, Michael Chorev, Ting Xu and Xuebin Qin

Use of Peripheral Blood Stem Cells in Tissue Engineering

Journal: Current Tissue Engineering
Volume: 1,Issue: 1
Page: 63-74
Authors: Kiminobu Sugaya, Ruben Berrocal Timmons and Tonia Patch

Heat Shock Proteins (HSPs) Based Anti-Cancer Vaccines

Journal: Current Molecular Medicine
Volume: 12,Issue: 9
Page: 1183-1197
Authors: D.R. Ciocca, N. Cayado-Gutierrez, M. Maccioni and F.D. Cuello-Carrion

Ofatumumab: A Novel Anti-CD20 Monoclonal Antibody for the Treatment of Chronic Lymphocytic Leukemia

Journal: Current Drug Therapy
Volume: 7,Issue: 4
Page: 281-289
Authors: Ravindra R. Chuda, Prakash Vishnu and David Aboulafia

New Benzothiazole/thiazole-Containing Hydroxamic Acids as Potent Histone Deacetylase Inhibitors and Antitumor Agents

Journal: Medicinal Chemistry
Volume: 9,Issue: 8
Page: 1051-1057
Authors: Truong Thanh Tung, Dao Thi Kim Oanh, Phan Thi Phuong Dung, Van Thi My Hue, Sang Ho Park, Byung Woo Han, Youngsoo Kim, Jin-Tae Hong, Sang-Bae Han and Nguyen-Hai Nam

TRAIL-Based Therapeutic Approaches for the Treatment of Pediatric Malignancies

Journal: Current Medicinal Chemistry
Volume: 20,Issue: 17
Page: 2254-2271
Authors: C. Gasparini, L. Vecchi Brumatti, L. Monasta and G. Zauli

From Bortezomib to other Inhibitors of the Proteasome and Beyond

Journal: Current Pharmaceutical Design
Volume: 19,Issue: 22
Page: 4025-4038
Authors: Daniela Buac, Min Shen, Sara Schmitt, Fathima Rani Kona, Rahul Deshmukh, Zhen Zhang, Christine Neslund-Dudas, Bharati Mitra and Q. Ping Dou

Pioglitazone and Cancer: Angel or Demon?

Journal: Current Pharmaceutical Design
Volume: 19,Issue: 27
Page: 4913-4929
Authors: Michael S. Kostapanos, Moses S. Elisaf and Dimitri P. Mikhailidis

A Structural Insight into Hydroxamic Acid Based Histone Deacetylase Inhibitors for the Presence of Anticancer Activity

Journal: Current Medicinal Chemistry
Volume: 21,Issue: 23
Page: 2642-2664
Authors: H. Rajak, A. Singh, K. Raghuwanshi, R. Kumar, P.K. Dewangan, R. Veerasamy, P.C. Sharma, A. Dixit and P. Mishra

Origins and Consequences of AID Expression in Lymphoid Neoplasms

Journal: Current Immunology Reviews
Volume: 9,Issue: 2
Page: 72-85
Authors: Damien Montamat-Sicotte, Florencia Palacios, Javier M. Di Noia and Pablo Oppezzo

Targeted Radionuclide Therapy - An Overview

Journal: Current Radiopharmaceuticals
Volume: 6,Issue: 3
Page: 152-180
Authors: Ashutosh Dash, F. F. (Russ) Knapp and M. R.A. Pillai

Autologus Stem Cell Transplatation as a Care Option in Elderly Patients. A Review

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 13,Issue: 9
Page: 1419-1429
Authors: Lucia Fratino, Maurizio Rupolo, Mario Mazzuccato, Massimiliano Berretta, Arben Lleshi, Umberto Tirelli and Mariagrazia Michieli

Choosing Optimal Firstline Helicobacter pylori Therapy: a View from a Region with High Rates of Antibiotic Resistance

Journal: Current Pharmaceutical Design
Volume: 20,Issue: 28
Page: 4510-4516
Authors: Alexander A. Nijevitch, Bulat Idrisov, Elsa N. Akhmadeeva and David Y. Graham

Population Based Helicobacter pylori Screening and Eradication: Advances Versus Side Effects

Journal: Current Pharmaceutical Design
Volume: 20,Issue: 28
Page: 4501-4509
Authors: Prof Bojan Tepes

Overview of Mechanisms of Cancer Stem Cell Drug Resistance

Journal: Current Signal Transduction Therapy
Volume: 8,Issue: 3
Page: 180-192
Authors: Bozena Kaminska, Dorota Weronika Kulesza and Kavita Ramji

HDAC Inhibitors as Novel Anti-Cancer Therapeutics

Journal: Recent Patents on Anti-Cancer Drug Discovery
Volume: 10,Issue: 2
Page: 145-162
Authors: Cristabelle De Souza and Biswa P. Chatterji

Genetics of Bladder Malignant Tumors in Childhood

Journal: Current Genomics
Volume: 17,Issue: 1
Page: 14-32
Authors: Andrea Zangari, Johan Zaini and Caterina Gulia

Organ Preference of Cancer Metastasis and Metastasis-Related Cell Adhesion Molecules Including Carbohydrates

Journal: Cardiovascular & Hematological Disorders-Drug Targets
Volume: 15,Issue: 3
Page: 164-186
Authors: Takanori Kawaguchi

Histone Modifications as Molecular Targets in Nasopharyngeal Cancer

Journal: Current Medicinal Chemistry
Volume: 23,Issue: 2
Page: 186-197
Authors: Sukanya Shyamasundar, S. Thameem Dheen and B. Huat Bay

The Role Oxidative Stress in the Pathogenesis of Eye Diseases: Currnt Status and a Dual Role of Physical Activity

Journal: Mini-Reviews in Medicinal Chemistry
Volume: 16,Issue: 3
Page: 241-257
Authors: Joanna Kruk, Katarzyna Kubasik-Kladna and Hassan Y. Aboul-Enein

Biosynthesis of Anti-Proliferative Gold Nanoparticles Using Endophytic Fusarium oxysporum Strain Isolated from Neem (A. indica) Leaves

Journal: Current Topics in Medicinal Chemistry
Volume: 16,Issue: 18
Page: 2036-2042
Authors: Ejaz Ahmad Siddiqui, Absar Ahmad, Anju Julius, Asad Syed, Shadab Khan, Mahesh Kharat, Kalpana Pai, Narendra Kadoo and Vidya Gupta

Phytochemicals as Adjunctive with Conventional Anticancer Therapies

Journal: Current Pharmaceutical Design
Volume: 22,Issue: 27
Page: 4201-4218
Authors: Mohammad Hosein Farzaei, Roodabeh Bahramsoltani and Roja Rahimi

Functional and Clinical Significance of the Integrin Alpha Chain CD49d Expression in Chronic Lymphocytic Leukemia

Journal: Current Cancer Drug Targets
Volume: 16,Issue: 8
Page: 659-668
Authors: Michele Dal Bo, Erika Tissino, Dania Benedetti, Chiara Caldana, Riccardo Bomben, Giovanni Del Poeta, Gianluca Gaidano, Francesca Maria Rossi, Pietro Bulian, Antonella Zucchetto and Valter Gattei

Co-Delivery of Epirubicin and siRNA Using Functionalized Mesoporous Silica Nanoparticles Enhances In vitro and In vivo Drug Efficacy

Journal: Current Drug Delivery
Volume: 13,Issue: 7
Page: 1176-1182
Authors: Mohammad Yahya Hanafi-Bojd, Mahmoud Reza Jaafari, Navid Ramezanian, Khalil Abnous and Bizhan Malaekeh-Nikouei

Polyketide Natural Products, Acetogenins from Graviola (Annona muricata L), its Biochemical, Cytotoxic Activity and Various Analyses Through Computational and Bio-Programming Methods

Journal: Current Pharmaceutical Design
Volume: 22,Issue: 34
Page: 5204-5210
Authors: Keerthana Prabhakaran, Gnanam Ramasamy, Uma Doraisamy, Jayakanthan Mannu, Rajamani K. and Jayadeepa Rajamani Murugesan

EGFR and EML4-ALK Updated Therapies in Non-Small Cell Lung Cancer

Journal: Recent Patents on Anti-Cancer Drug Discovery
Volume: 11,Issue: 4
Page: 393-400
Authors: Ramon Andrade de Mello, Davi J. J. Liu, Pedro N. Aguiar and Hakaru Tadokoro

Identification of Novel Inhibitors for Disrupting EZH2-EED Interactions Involved in Cancer Epigenetics: An In-Silico Approach

Journal: Current Proteomics
Volume: 13,Issue: 4
Page: 313-321
Authors: Utkarsh Raj, Himansu Kumar, Saurabh Gupta and Pritish Kumar Varadwaj


Do We Need Full Donor Chimerism? How Alloreactive Cell Therapies without Substantial Engraftment Might Treat Hematologic Cancers

Journal: Current Drug Targets
Volume: 18,Issue: 3
Page: 281-295
Authors: Elizabeth F. Krakow, Hui-Sheng Ai, Brian Shaffer, Jean-Sebastien Delisle, Kai-Xun Hu and Anthony D. Sung

Kinase Inhibitor Indole Derivatives as Anticancer Agents: A Patent Review

Journal: Recent Patents on Anti-Cancer Drug Discovery
Volume: 12,Issue: 1
Page: 55-72
Authors: Anuj K. Rathi, Riyaz Syed, Vijay Singh, Han-Seung Shin and Rahul V. Patel

miR-15b and miR-21 as Circulating Biomarkers for Diagnosis of Glioma

Journal: Current Genomics
Volume: 16,Issue: 5
Page: 304-311
Authors: Pietro Ivo D’Urso, Oscar Fernando D’Urso, Cosimo Damiano Gianfreda, Valeria Mezzolla, Carlo Storelli and Santo Marsigliante

Natural and Structure-based RXR Ligand Scaffolds and Their Functions

Journal: Current Topics in Medicinal Chemistry
Volume: 17,Issue: 6
Page: 631-662
Authors: Marta Dominguez, Susana Alvarez and Angel R. de Lera

Editorial: New Therapies, Markers and Therapeutic Targets in HCV Chronic Infection and HCV Extrahepatic Manifestations

Journal: Current Drug Targets
Volume: 18,Issue: 7
Page: 752-755
Authors: Alessandro Antonelli and Mauro Pistello

HTLV-1 Associated Neurological Disorders

Journal: Current Topics in Medicinal Chemistry
Volume: 17,Issue: 12
Page: 1320-1330
Authors: Muhammad Yasir Khan, Ishaq Nasib Khan, Muhammad Farman, Saleh Al Karim, Ishtiaq Qadri, Muhammad Amjad Kamal, Khalid Al Ghamdi and Steve Harakeh

Atomoxetine Protects Against NMDA Receptor-mediated Hippocampal Neuronal Death Following Transient Global Cerebral Ischemia

Journal: Current Neurovascular Research
Volume: 14,Issue: 2
Page: 158-168
Authors: Joon Ha Park, Yang Hee Kim, Ji Hyeon Ahn, Soo Young Choi, Seongkweon Hong, Sung Koo Kim, Il Jun Kang, Young-Myeong Kim, Tae-Kyeong Lee, Moo-Ho Won and Choong-Hyun Lee

Discovery of Potent Bruton’s Tyrosine Kinase Inhibitors Using Ligand Based Modeling

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 17,Issue: 2
Page: 265-275
Authors: Wafa A. Mera, Malek Alzihlif, Mutasem O. Taha and Mohammad A. Khanfar

Non Coding RNAs: A New Avenue for the Self-Tailoring of Blood Cancer Treatment

Journal: Current Drug Targets
Volume: 18,Issue: 1
Page: 35-55
Authors: Gabriella Misso, Mayra Rachele Zarone, Anna Grimaldi, Maria Teresa Di Martino, Angela Lombardi, Hiromichi Kawasaki, Paola Stiuso, Pierfrancesco Tassone, Pierosandro Tagliaferri and Michele Caraglia

Possible Molecular Interactions of Bexarotene - A Retinoid Drug and Alzheimer's Aβ Peptide: A Docking Study

Journal: Current Alzheimer Research
Volume: 14,Issue: 3
Page: 327-334
Authors: Zeenat Mirza and Mohd Amin Beg

CD20-based Immunotherapy of B-cell Derived Hematologic Malignancies

Journal: Current Cancer Drug Targets
Volume: 17,Issue: 5
Page: 423-444
Authors: Dariush Shanehbandi, Jafar Majidi, Tohid Kazemi, Behzad Baradaran and Leili Aghebati-Maleki

Treatment of HCV-Related Mixed Cryoglobulinemia

Journal: Current Drug Targets
Volume: 18,Issue: 7
Page: 794-802
Authors: Dilia Giuggioli, Marco Sebastiani, Michele Colaci, Poupak Fallahi, Laura Gragnani, Anna Linda Zignego, Alessandro Antonelli and Clodoveo Ferri

A Systematic in-silico Analysis of Helicobacter pylori Pathogenic Islands for Identification of Novel Drug Target Candidates

Journal: Current Genomics
Volume: 18,Issue: 5
Page: 450-465
Authors: Deepthi Nammi, Nagendra S. Yarla, Vladimir N. Chubarev , Vadim V. Tarasov, George E. Barreto, Amita Martin Corolina Pasupulati , Gjumrakch Aliev and Nageswara Rao Reddy Neelapu

Purine Nucleoside Analogs as Immunosuppressive and Antineoplastic Agents: Mechanism of Action and Clinical Activity

Journal: Current Medicinal Chemistry
Volume: 13,Issue: 26
Page: 3165-3189
Authors: Tadeusz Robak, Ewa Lech-Maranda, Anna Korycka and Ewa Robak

Rationally Designed Anti-mitotic Agents with Pro-Apoptotic Activity

Journal: Current Pharmaceutical Design
Volume: 7,Issue: 16
Page: 1627-1639
Authors: Fatih M. Uckun

Novel Monoclonal Antibodies for the Treatment of Chronic Lymphocytic Leukemia

Journal: Current Cancer Drug Targets
Volume: 8,Issue: 2
Page: 156-171
Authors: Tadeusz Robak

Should the Status of the Pathway Mediated by BRCA1 and BRCA2 be Evaluated Before Selecting Cancer Chemotherapy Drugs?

Journal: Current Pharmacogenomics
Volume: 5,Issue: 4
Page: 280-291
Authors: Bernard Friedenson

New Molecular Targets in the Treatment of NSCLC

Journal: Current Pharmaceutical Design
Volume: 19,Issue: 30
Page: 5333-5343
Authors: Clorinda Schettino, Maria Anna Bareschino, Paola Claudia Sacco, Paolo Maione, Antonio Rossi, Francesca Casaluce, Assunta Sgambato and Cesare Gridelli

Farnesyltransferase Inhibitors: A Comprehensive Review Based on Quantitative Structural Analysis

Journal: Current Medicinal Chemistry
Volume: 20,Issue: 38
Page: 4888-4923
Authors: N. S.H.N. Moorthy, S. F. Sousa, M. J. Ramos and P. A. Fernandes

Statins and Cancer

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 14,Issue: 5
Page: 706-712
Authors: Natalia G. Vallianou, Alexandra Kostantinou, Marios Kougias and Christos Kazazis

Survey of Epstein Barr Virus (EBV) Immunogenic Proteins and their Epitopes: Implications for Vaccine Preparation

Journal: Recent Patents on Anti-Infective Drug Discovery
Volume: 9,Issue: 1
Page: 62-76
Authors: Julius Rajcani, Kalman Szenthe, Ferenc Banati and Susan Szathmary

Standardization of Procedures for the Preparation of 177Lu- and 90Y-labeled DOTA-Rituximab Based on the Freeze-dried Kit Formulation

Journal: Current Radiopharmaceuticals
Volume: 8,Issue: 1
Page: 62-68
Authors: Wioletta Wojdowska, Urszula Karczmarczyk, Michal Maurin, Piotr Garnuszek and Renata Mikolajczak

A Pan-Cancer Review of ALK Mutations: Implications for Carcinogenesis and Therapy

Journal: Current Cancer Drug Targets
Volume: 15,Issue: 4
Page: 327-336
Authors: Nick Ka Ming Yau, Andrew Yuon Fong, Hiu Fung Leung, Krista Roberta Verhoeft, Qin Ying Lim, Wai Yip Lam, Ian Chi Kei Wong and Vivian Wai Yan Lui

Quality Survival with Fertility after Gynaecological and other Cancers

Journal: Current Women`s Health Reviews
Volume: 12,Issue: 2
Page: 115-125
Authors: Shakuntala A. Chhabra

Strong Anti-tumorous Potential of Nardostachys jatamansi Rhizome Extract on Glioblastoma and In Silico Analysis of its Molecular Drug Targets

Journal: Current Cancer Drug Targets
Volume: 17,Issue: 1
Page: 74-88
Authors: Himanshi Kapoor, Nalini Yadav, Madhu Chopra, Sushil Chandra Mahapatra and Veena Agrawal

Editorial Review of 2014

Journal: Current Radiopharmaceuticals
Volume: 7,Issue: 1
Page: 1-4
Authors: Sean L. Kitson and Luigi Mansi

Results 1 - 406 of 406